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Zusammenfassung 
Regulatorische CD4+CD25+ T-Zellen (Tregs) spielen eine wichtige Rolle bei der Aufrechterhaltung 
des homeostatischen Gleichgewichts und der peripheren Selbst-Toleranz. In vorausgegangenen 
Untersuchungen unserer Arbeitsgruppe konnten Subpopulationen von CD4+ Tregs identifiziert 
werden, die sich durch die Expression des Integrins αEβ7 auszeichnen. αE-exprimierende Treg 
Subpopulationen weisen einen Effektor/Memory-ähnlichen Phänotyp auf und sind mit verschiedenen 
Homingrezeptoren ausgestattet, die ihre Einwanderung in entzündete Gewebe ermöglichen. Diese 
phänotypischen Merkmale und das darausfolgende Wanderungsverhalten der αE+ Treg-Populationen 
bilden die Grundlage für ihre Fähigkeit, eine bestehende Entzündung in nicht-lymphoiden Geweben 
zu unterdrücken. In der vorliegenden Arbeit wurden die Umstände, die zur Entstehung von 
Effektor/Memory αE+ Tregs in vivo führen, näher untersucht. Dabei konnte gezeigt werden, dass die 
αE
+ Treg-Populationen unter physiologischen Bedingungen in gesunden Mäusen einen hohen Anteil 
sich-teilender Zellen aufweisen. Diese in vivo Proliferation war zum Teil abhängig von der 
kommensalen Mikroflora im Darm der untersuchten Tiere. Dementsprechend führte das Fehlen von 
mikrobiellen Stimuli zur Reduktion der absoluten Zahl von CD4+Foxp3+ Tregs, wahrscheinlich als 
Folge der verringerten Zellteilung von Tregs in den darm-assozierten lymphoiden Geweben (GALT). 
Darüberhinaus konnte in einem adoptiven Transfermodel mit transgenen T-Zell-Subpopulationen aus 
DO11.10 Mäusen gezeigt werden, dass αE+Foxp3+ Effektor/Memory Tregs nicht nur durch 
Differenzierung naiver CD4+CD25+ Tregs entstehen, sondern, dass sie unter tolerogener Antigengabe 
in den GALT auch durch de novo Induktion aus konventionellen T-Zellen hervorgehen können. Diese 
Ergebnisse deuten darauf hin, dass es sich bei den αE+ Tregs um Effektor/Memory Zellen handelt, die 
eine hohe Teilungsrate aufweisen und sowohl aus konventionellen naiven T-Zellen in der Peripherie, 
als auch aus thymus-generierten naïven CD4+CD25+ Tregs entstehen können. Im Zusammenhang mit 
der beobachteten Rolle der kommensalen Mikroflora deuten diese Ergebnisse auf einen wichtigen 
Mechanismuns bei der Homeostase der Foxp3+ Treg-Populationen im Allgemeinen und der αE+Foxp3+ 
Tregs im Besonderen hin. Sie legen den Schluss nahe, dass das spezifische mukosale 
Mikroenvironment sowohl die Expansion als auch die Konvertierung von Tregs fördert.  
Desweiteren wurde untersucht in wie weit naïve CD4+CD25+ Tregs für die Ausbildung eines 
gewebespezifischen Homingrezeptor-Phänotyps empfänglich sind. In vitro Kultur-Systeme zeigten 
dabei, dass sich Tregs, ähnlich wie konventionelle T-Zellen, mit organspezifischen 
Migrationseigenschaften versehen lassen, die eine effiziente Wanderung in den Darm oder in die Haut 
ermöglichen. Die Aktivierung naïver CD4+CD25+ Tregs in Anwesenheit von DCs aus mesenterialen 
Lymphknoten oder des löslichen Faktors Retinolsäure führte zur Ausbildung von darmspezifischen 
α4β7
+
 Tregs, wohingegen die Aktivierung in Anwesenheit von DCs aus peripheren Lymphknoten oder 
IL-12 zur Entstehung hautmigrierender E/P-Selektin-Ligand+ Tregs führte. Zudem konnte gezeigt 
werden, dass durch Expansion unter polarisierenden Bedingungen weder die Foxp3-Expression von 
CD4+CD25+ Tregs noch ihre suppressorische Kapazität in vitro verringert wurde. Diese Ergebnisse 
 weisen darauf hin, dass das Wanderungsverhalten von CD4+CD25+ Tregs während der Aktivierung 
durch das gewebespezifische Mikroenvironment und organspezifische DCs bestimmt wird. Zudem 
legen die Daten den Schluss nahe, dass die Herstellung von Tregs mit spezifischen 
Wanderungseigenschaften eine Option für therapeutische Anwendungen in der adoptiven T-Zell 
Therapie sein könnte.  
 
 
 Abstract 
Regulatory CD4+CD25+ T cells (Tregs) play an important role in immune homeostasis and in the 
maintenance of self-tolerance. Our group has previously identified a subset of CD4+ Tregs 
characterised by expression of the integrin αEβ7, which displays an effector/memory-like phenotype 
and is equipped with homing receptors allowing their migration into inflamed sites. These phenotypic 
and migratory characteristics are required for the capacity of αE+ Tregs to suppress ongoing 
inflammation in non-lymphoid tissues. In the present study the circumstances favouring in vivo 
generation of effector/memory-like αE+ Tregs were analysed. The results presented here show that αE+ 
effector/memory-like Treg subsets contain a large fraction of cycling cells under physiologic 
conditions in healthy mice. This in vivo proliferation depended, at least in part, on intestinal 
commensal microflora. Absence of microbial stimuli led to reduction in the total number of 
CD4+Foxp3+ Tregs, most likely as a result of decreased Treg proliferation within the gut-associated 
lymphoid tissue (GALT). Furthermore, adoptive transfer of transgenic T cell subsets from DO11.10 
mice provided clear evidence that αE+Foxp3+ effector/memory Tregs not only developed by 
differentiation of naïve-like CD4+CD25+ Tregs, but also were generated de novo from naïve 
conventional T cells under tolerogenic conditions of antigen delivery in the GALT. These findings 
suggest that Tregs expressing the integrin αEβ7 are effector/memory Tregs with a high turnover rate 
that can develop from both naïve T cells converted into Tregs in the periphery as well as from thymic-
derived naïve CD4+CD25+ Tregs differentiating into an effector/memory stage. In combination with 
the observed role of the commensal microflora, these results imply an important mechanism for the 
maintenance of Foxp3+ Tregs in general and αE+Foxp3+ Tregs in particular and indicate that the 
mucosal microenvironment favours both expansion and conversion of Tregs. 
In addition, susceptibility of naïve CD4+CD25+ Tregs to acquire tissue-specific homing receptor 
phenotypes was investigated. In vitro culture systems demonstrated that Tregs, similarly to 
conventional T cells, could be configured with organ-selective homing properties allowing efficient 
targeting into gut and skin. Priming of naïve CD4+CD25+ in the presence of either dendritic cells from 
mesenteric and peripheral LN, or the soluble factors retinoic acid and IL-12 induced α4β7+ mucosa-
seeking and E/P-selectin ligand+ skin-seeking Tregs, respectively. Importantly, the expansion under 
polarising conditions did not change Foxp3 expression and in vitro suppressive capacity of 
CD4+CD25+ Tregs. These results indicate that the tissue microenvironment and organ-specific 
dendritic cells shape migratory properties of naïve CD4+CD25+ Tregs during priming and suggest that 
generation of Tregs with specific homing properties for therapeutic purposes in adoptive T cell 
therapy might be a feasible option.  
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1 Introduction 
The immune system is a remarkable defence mechanism, found in its most advanced form in higher 
vertebrates. It provides the means to make rapid, highly specific and protective responses against 
potentially pathogenic microorganisms including bacteria, viruses, fungi and parasites, thus, creating a 
state of protection from infectious disease named immunity. Examples of immunodeficiency, as seen 
in both genetically determined diseases and in the acquired immunodeficiency syndrome (AIDS), 
illustrate the central role of the immune response in protection against microbial infection. However, 
not only a deficient but also an excessive immune response as seen in autoimmunity and 
hypersensitivity reactions can lead to tissue damage and fatal outcome. Therefore, a balanced 
response, which is able to discriminate between self and non-self, is the prime challenge of the 
immune system.  
Innate immunity acts as a first line of defence against infectious agents. The defences range from 
external physical and biochemical barriers (epithelial cells, mucous surfaces) to an internal defence 
involving e.g. phagocytes, dendritic cells (DC), natural killer (NK) cells and soluble mediators such as 
plasma proteins (e.g. complement cascade, C-reactive protein). The innate immune system relies on a 
set of germ-line encoded receptors named pattern-recognition receptors (PRRs), which are not specific 
to a particular pathogen but rather recognise conserved molecular patterns associated with pathogens 
(pathogen-associated molecular patterns, PAMPs) (Medzhitov and Janeway, 2000).  
In contrast, the adaptive immune response is characterised by a high degree of specificity to individual 
pathogens by virtue of antigen-specific receptors and the ability to form a stable memory ensuring 
increased protection against re-infection. T cells, together with B cells, form the major part of adaptive 
immunity. T cells can efficiently recognise and eliminate infected cells and support the function of 
other cellular components of the immune system, such as B cells and macrophages. A fundamental 
basis for an adaptive T cell response is the large diversity of the T cell repertoire, which is generated 
by random rearrangement of gene sequences coding for a functional T cell receptor (TCR) during 
development of T cells in the thymus. However, the high degree of diversity carries the inherent 
danger of reactivity against endogenous structures of the organism and therefore sophisticated control 
mechanisms are required to ensure a state of unresponsiveness – tolerance – to self-antigens and other 
harmless determinants. Thus, the prime task of the immune system is to sustain the balance between 
immunity and tolerance. A set of central and peripheral tolerance mechanisms has evolved to ensure 
such discrimination at different levels, and failure can lead to autoimmune diseases like type1 
diabetes, multiple sclerosis or rheumatoid arthritis (Sakaguchi, 2000).  
Central tolerance is a function of the thymus and involves a combination of negative and positive 
selection processes, which eliminate most of the autoreactive T cell specificities (Kappler, et al., 1987; 
Kisielow, et al., 1988) while providing the large diversity of specificities to foreign antigen. However, 
elimination of self-reactive T cells during thymic development is not complete and therefore 
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additional, peripheral mechanisms are required to establish immunologic self-tolerance. These 
mechanisms include anergy and clonal deletion of autoreactive T cells as well as ignorance to self-
antigen (Arnold, et al., 1993; Miller and Heath, 1993; Van Parijs and Abbas, 1998). In addition, it is 
increasingly recognised that dominant tolerance processes are in place, which are attributed largely to 
distinct subsets of T cells actively protecting from autoimmunity. The initial studies postulating the 
existence of T cells engaged in dominant tolerance date back to the early 1970s, when they became 
known as suppressor T cells (Gershon and Kondo, 1970; Ha and Waksman, 1973). However, due to 
lack of specific markers and the inability to identify the suppressive factor, the whole concept was 
discussed controversially and as a result interest gradually faded.  
 
1.1 CD4+ regulatory T cells  
When Sakaguchi and colleagues identified the surface molecule CD25 as a marker for CD4+ T cells 
with suppressive capacity, they initiated the re-emergence of the suppressor T cell paradigm and 
fuelled a remarkable interest in this field of research (Sakaguchi, et al., 1995). They found that 5-10% 
of CD4+ T cells constitutively expressed the α−chain of the high affinity interleukin (IL)-2 receptor, a 
molecule associated with T cell activation. Using a model of adoptive transfer into immunodeficient 
recipient mice these authors demonstrated that CD4+CD25- cells caused a wide spectrum of 
autoimmune disease in the host, while the presence of CD4+CD25+ was able to prevent the 
development of disease. These initial results indicated that regulatory T cells (Tregs) are present in the 
T cell repertoire of normal mice and that they are enriched within the small subset of CD4+CD25+ T 
cells. Much evidence has accumulated since to establish the importance of Tregs in various animal 
models of organ-specific autoimmunity, allergic responses, anti-tumor immunity, allograft rejection 
and immune responses to pathogens (Sakaguchi, 2004), including observations showing that Tregs 
control systemic homeostasis and total lymphocyte numbers (Annacker, et al., 2000). In addition, 
identification of human CD4+CD25+ cells with similar properties (Baecher-Allan, et al., 2001) and 
functional deficiency of the same observed in human autoimmune disease (Viglietta, et al., 2004), 
contributed to the acceptance of the proposed concept.  
 
1.1.1 Features of CD4+ Tregs 
Further characterisation of CD4+CD25+ Tregs revealed several distinct features as opposed to the 
CD4+CD25- T cell population. Besides CD25, Tregs were found to constitutively express other 
molecules associated with TCR-mediated activation such as cytolytic T lymphocyte-associated 
antigen 4 (CTLA-4) (Takahashi, et al., 2000) and glucocorticoid-induced TNF receptor (GITR) 
(Gavin, et al., 2002; McHugh, et al., 2002; Shimizu, et al., 2002). As these markers are shared with 
conventional T cells upon activation, their use is somewhat limited in the context of inflammatory 
immune responses. The search for more specific markers identifying the Treg subset produced some 
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potential candidates such as neuropilin-1 (Bruder, et al., 2004) and G protein-coupled receptor (GPR) 
83 (Hansen, et al., 2006), however, the transcription factor forkhead box protein 3 (Foxp3) has 
emerged as the most reliable lineage specification marker to date. Due to the intracellular expression 
pattern, however, the ability to isolate pure Foxp3+ cells for enhanced phenotypic characterisation and 
functional studies has been delayed until only recently when new tools became available such as 
antibodies for flow cytometric analysis and green fluorescent protein (GFP)-Foxp3 fusion-protein 
reporter knock in mice (Fontenot, et al., 2005). 
Despite their activation-related phenotype Tregs have been characterised as anergic, as they do not 
respond to TCR-mediated stimulation in vitro and only high amounts of exogenous IL-2 can overcome 
their hypo-responsiveness (Thornton and Shevach, 1998). Another characteristic feature of Tregs is 
their ability to inhibit activation of other T cells in vitro. It was demonstrated that co-culture with 
CD4+CD25+ suppressed the proliferation of CD4+CD25- T cells upon TCR-mediated activation by 
inhibiting the production of IL-2. Due to the limitations regarding Treg-specific surface markers this 
dominant characteristic allowed functional identification of potential Tregs and thus, has since been 
used widely as a defining property of Tregs in general. Their suppression was shown to depend on 
direct cell-cell contact and addition of exogenous IL-2 is able to abrogate the inhibition of CD4+CD25- 
cells in vitro (Thornton and Shevach, 1998). Importantly, while the suppressive activity requires 
antigen-specific or CD3-mediated activation of CD4+CD25+ Tregs, once activated they inhibit both 
CD4+ and CD8+ T cell proliferation in an antigen-unspecific manner (Takahashi, et al., 1998; 
Thornton and Shevach, 2000).  
 
1.1.2 Mode of action  
Although many different in vitro and in vivo systems have been used to elucidate the 
immunosuppressive mechanism used by Tregs, no single mode of action has been identified so far. In 
vitro the contribution of anti-inflammatory cytokines such as IL-10 and transforming growth factor 
(TGF)-β has been largely excluded (Piccirillo, et al., 2002; Takahashi, et al., 1998), while competition 
for IL-2 was proposed as a possible mechanism of suppression and growth-inhibition. By virtue of 
their high level expression of CD25, Tregs may consume IL-2 produced by co-cultured CD4+CD25- 
cells much more efficiently than the latter (De La Rosa, et al., 2004). However, recent evidence argues 
against the above mechnism, as peripheral Foxp3+ Tregs from IL-2Rα-/- mice displayed similar 
suppressive capacity in vitro as wild-type (wt) Tregs (D'Cruz and Klein, 2005; Fontenot, et al., 2005) 
indicating that additional mechanisms are involved. 
Conflicting data exist also concerning the role of constitutively expressed CTLA-4 in the suppressive 
function of Tregs. Upon blockade with specific anti-CTLA-4 antibodies suppressive activity of Tregs 
was abrogated in vitro (Takahashi, et al., 2000) and in a mouse model of colitis (Read, et al., 2000). 
As one possible mechanism it was proposed that Tregs initiate tryptophan catabolism in DCs through 
CTLA-4/B7-mediated interaction and induction of indoleamin 2,3 dioxygenase (IDO) (Fallarino, et 
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al., 2003), leading to deprivation of the essential amino acid tryptophan followed by growth inhibition. 
Furthermore, induction of TGF-β secretion after crosslinking of CTLA-4 on Tregs was reported 
(Chen, et al., 1998). However, others have not identified a role for CTLA-4 (Thornton and Shevach, 
1998) and CTLA-4-/- Tregs also exhibit some suppressive function (Takahashi, et al., 2000).  
Contrary to the in vitro results, a role for immunosuppressive cytokines in vivo has been observed in 
several studies. CD4+CD25+ were found to produce IL-10 in vivo (Annacker, et al., 2001; Klein, et al., 
2003; Uhlig, et al., 2006) and this production was required, at least partially, for their suppressive 
function (Asseman, et al., 1999; Uhlig, et al., 2006). The contribution of TGF-β to the suppressive 
effect of Tregs is discussed more controversially, mainly because TGF-β is a highly pleiotropic 
cytokine, which is produced by many different cell types and has differential effects on a wide range 
of responder cells (Letterio and Roberts, 1998). Nevertheless, blocking of TGF-β was found to 
abrogate suppressive function of Tregs in experimental colitis (Liu, et al., 2003; Powrie, et al., 1996), 
signalling through the TGF-β receptor was required for functional activation of Tregs (Huber, et al., 
2004) and CD4+CD25+ mediated suppression of cytolytic activity of CD8+ T cells in tumor rejection 
depended on TGF-β signalling in CD8+ target cells (Chen, et al., 2005). Although TGF-β mRNA 
expression was detected in CD4+CD25+ (Asano, et al., 1996), the above findings do not necessarily 
require that Tregs produce TGF-β themselves, consistent with the observation that CD4+CD25+ from 
TGF-β-/- mice prevented colitis in a similar way as wt Tregs and that suppression was dependent on 
non-Treg-produced TGF-β (Fahlen, et al., 2005).  
Collectively, the available data confirm an important role for CTLA-4, IL-10 and TGF-β in 
suppression of autoimmune responses, while the exact mechanisms of action with regard to Tregs 
remain to be defined.  
 
1.1.3 Foxp3  
A major breakthrough in the field of dominant tolerance was the identification of Foxp3 as the first 
molecule specifically associated with the Treg phenotype. In 2001 Brunkow and colleagues laid the 
basis by identifying Foxp3 as a new member of the forkhead/winged-helix family of transcriptional 
regulators and as the defective gene in the scurfy mouse, a spontaneous X-linked recessive mouse 
mutant. The phenotype of scurfy mice is characterised by lethal lymphoproliferative disease similar to 
CTLA-4-/- and TGF-β-/- mice (Brunkow, et al., 2001). In addition, gene defects of the human 
homologue FOXP3 were found to be the cause of a lymphoproliferative disorder with a wide spectrum 
of autoimmune disease known as immune dysregulation, polyendocrinopathy enteropathy, X-linked 
syndrome (IPEX) (Bennett, et al., 2001).  
Subsequent studies revealed that Foxp3 is specifically expressed by CD4+CD25+ Tregs and that both 
scurfy mice and Foxp3-/- mice exhibit similar phenotypes and are deficient in CD4+CD25+ Tregs. 
Finally, over-expression of Foxp3 in CD4+CD25- cells converted them into cells with suppressive 
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properties similar to CD4+CD25+ Tregs (Fontenot, et al., 2003; Hori, et al., 2003; Khattri, et al., 2003). 
Furthermore, it was demonstrated that Foxp3 expression was required for thymic development of 
CD4+CD25+ Tregs (Fontenot, et al., 2003). Recent studies using GFP-Foxp3 fusion-protein reporter 
knock in mice have allowed more in-depths analysis of the relationship between CD25 and GFP-
Foxp3 (Foxp3gfp) expression on the single cell level and demonstrated that a significant proportion 
Foxp3gfp+ Tregs expressed little or no CD25. On the other hand, a fraction of CD25+ cells did not 
express Foxp3gfp and was identified as an activated/effector subset, which did not display suppressive 
capacity in vitro. Nevertheless, high levels of CD25 expression correlated well with Foxp3gfp 
(Fontenot, et al., 2005) and validated the usefulness of CD25 as a Treg marker, at least in the absence 
of overt inflammation.  
 
1.1.4 Origin of CD4+ Tregs 
The thymus has a central role not only in generating a diverse T cell repertoire for protective immunity 
against pathogens, but also in preventing unwanted immune responses against self by deleting 
autoreactive thymocytes. In addition, the thymus is also constantly generating regulatory T cells that 
exert dominant tolerance mechanisms in the periphery (Seddon and Mason, 2000).  
From a number of studies it is well documented that a fraction, if not all CD4+CD25+ Tregs develop in 
the thymus as a distinct lineage. Transfer of CD25+ depleted CD4+CD8- thymocytes into athymic mice 
results in various autoimmune diseases. Postnatally, CD4+CD25+ Tregs appear first in thymus before 
they become detectable in the periphery. They show similar phenotypic and functional properties as 
their peripheral counterparts (Itoh, et al., 1999). These findings clearly demonstrate that the thymus 
constantly produces Tregs. Foxp3 appears to be the most important single factor required for 
recruitment of thymocytes into the Treg pool (Fontenot, et al., 2003; Hori, et al., 2003; Khattri, et al., 
2003), while the exact signals driving expression/up-regulation of this lineage-specific transcription 
factor are not understood. Expression of Foxp3gfp+ was already detected at the CD4+CD8+ stage of 
thymocyte development, however, induction occurred preferentially at the CD4+CD8- stage (Fontenot, 
et al., 2005). Current evidence suggests that high affinity TCR interaction with self-peptide/MHC 
ligands is a prerequisite for development of CD4+CD25+ Tregs (Jordan, et al., 2001; Kawahata, et al., 
2002). Apparently, this interaction is not so high as to lead to depletion of Tregs during the negative 
selection process. Interestingly, in TCR-transgenic (TCR-tg) mouse models CD4+CD25+ Tregs are 
also present and they were found to express endogenous TCR α-chains. In contrast, CD4+CD25+ 
Tregs are absent in recombinase activation gene-2 (RAG-2)-deficient TCR-tg mice, indicating that 
thymic generation of CD4+CD25+ Tregs in TCR-tg mice is controlled by endogenous TCR gene 
rearrangement (Itoh, et al., 1999; Suto, et al., 2002).  
Expression of self-antigen on radioresistant elements of the thymus was found to be required for 
thymic development of CD4+CD25+ Tregs (Apostolou, et al., 2002) and a particular role for thymic 
cortical eptihelial cells in the selection process has been proposed (Bensinger, et al., 2001), while 
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recent data from the Foxp3 reporter mouse suggest an important role for the thymic medulla in driving 
development of Foxp3gfp+ thymocytes (Fontenot, et al., 2005). In addition to antigen-specific 
interactions accessory molecules such CD28, CTLA-4, Β7 and CD40 contribute to thymic generation 
of Tregs (reviewed by Sakaguchi (Sakaguchi, 2004)). Further studies are required to dissect the 
interplay of the different signals, which determine the fate of developing thymocytes. 
 
Apart from thymic generation of CD4+CD25+ Tregs there is accumulating evidence to suggest that 
regulatory T cells can be induced de novo from the conventional, naive CD4+ T cell pool both in vitro 
and in vivo. Immunosuppressive cytokines like TGF-β (Chen, et al., 2003; Fantini, et al., 2004) and 
IL-10 (Groux, et al., 1997), as well as immature DCs (Kretschmer, et al., 2005; Mahnke, et al., 2003) 
have been used to induce regulatory T cells with distinct properties. Generation of Tregs was also 
observed with various protocols of tolerance induction, i.e. oral, nasal and i.v. antigen-administration 
(Apostolou and von Boehmer, 2004; Hauet-Broere, et al., 2003; Hultkrantz, et al., 2005; Thorstenson 
and Khoruts, 2001; Unger, et al., 2003). However, the reported phenotypes of de novo induced Tregs 
are heterogeneous, particularly with respect to the expression of the Treg marker Foxp3.  
Due to the large heterogeneity of peripheral T cells with regulatory properties, thymic-derived 
CD4+CD25+Foxp3+ Tregs are generally referred to as natural Tregs in order to distinguish them from 
those subsets that were induced in the periphery. Natural CD4+CD25+ Tregs are Foxp3+ by definition, 
while not all peripherally generated Treg subsets express Foxp3. Among those are the Tr1 cells, which 
are characterised by the production of IL-10 upon repeated TCR-mediated stimulation in the presence 
of IL-10 (Barrat, et al., 2002; Groux, et al., 1997; Vieira, et al., 2004). Oral antigen administration 
results in the development of TGF-β -secreting Th3 cells (Chen, et al., 1994). They lack CD25 
expression and their suppressive activity relies solely on TGF-β and thus they are distinct from natural 
CD4+CD25+ Tregs both with respect to their phenotype and suppressive mechanism (Zhang, et al., 
2001).  
Taken together, these observations indicate that the peripheral pool of Tregs is composed of various 
different subsets with partially overlapping functional properties. Their relationship to each other is 
currently not well understood.  
 
1.1.5 Integrin αEβ7 expression on CD4+ Tregs 
Recent studies from our group and from others have identified the integrin αE (CD103) as a marker for 
murine CD4+ Tregs in secondary lymphoid organs (Banz, et al., 2003; Lehmann, et al., 2002; 
McHugh, et al., 2002; Zelenika, et al., 2002). Initially, expression of αEβ7 was predominantly ascribed 
to intraepithelial lymphocytes residing in the gut wall and other epithelial sites, i.e. skin and lung 
(Cerf-Bensussan, et al., 1987; Kilshaw and Murant, 1991; Picker, et al., 1994). Expression of αEβ7 is 
closely associated with mucosal tissues, where TGF-β, which transcriptionally regulates expression of 
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the αE subunit, is abundant (Kilshaw and Murant, 1991). The ligand for αEβ7, E-cadherin, is expressed 
on a variety of epithelial cells such as intestinal epithelial cells and Langerhans’ cells in the skin 
(Cepek, et al., 1994; Geiger and Ayalon, 1992). Consequently, the postulated function of αEβ7 is to 
provide retention within epithelial sites (Suffia, et al., 2005). This is in contrast to the closely related 
integrin α4β7, which mediates interaction of T cells with the gut-associated vascular endothelium and 
thereby controls trafficking to the intestine (Hamann, et al., 1994; Holzmann and Weissman, 1989). 
However, the exact function of αEβ7 is currently not clear, studies in αE-/- mice have not provided 
conclusive results. Deficiency in αEβ7 leads to modest reduction in the number of mucosal T cells and 
development of an age-related skin disorder when introduced to certain genetic backgrounds (Schon, 
et al., 1999; Schon, et al., 2000).  
Our group has previously shown that within the murine CD4+ Treg compartment αE and CD25 
identify phenotypically and functionally distinct Treg subsets. Using these markers it was possible to 
subdivide the Treg compartment into naive-like αE-CD25+ and effector/memory-like αE+CD25+ or 
αE
+CD25- cells (Huehn, et al., 2004). Each of these Treg subsets expresses Foxp3 mRNA and displays 
suppressive capacity in vitro and in vivo. While the αE+CD25+ subset always exhibited the most potent 
inhibitory capability, αE+CD25- cells were functional in preventing experimental colitis but less 
effective in suppressing the proliferation of naïve responder cells in vitro (Lehmann, et al., 2002).  
Most strikinkgly, expression of αE was found to correlate with an effector/memory phenotype. αE+ 
Tregs displayed reduced amounts of T cell recepor excision circles (TREC), expressed increased 
amounts of molecules such as CD44, CD54, CD29, LFA-1 and P-selectin ligand, reduced levels of 
CD62L and migrated in response to inflammatory chemokines in vitro. In contrast, αE-CD25+ Tregs 
displayed a naïve-like phenotype characterised by high amounts of CD62L and increased chemotactic 
sensitivity to CCR7 ligands. These differential phenotypic properties resulted in selective homing 
patterns upon adoptive transfer (Huehn, et al., 2004).  
Ultimately, these distinct characteristics were directly coupled to the functional activity of the 
respective subsets in vivo, indicating that appropriate location was a prerequisite for suppressive 
capacity. Naïve-like αE-CD25+ Tregs suppressed proliferation of naïve antigen-specific T cells in 
draining lymph nodes, while αE+ Tregs where much more efficient in ameliorating acute skin 
inflammation in a model of delayed-type hypersensitivity (DTH) (Siegmund, et al., 2005). 
Collectively, the above findings led to the hypothesis that there is division of labour between distinct 
subsets of naturally occurring Tregs. In order to suppress the sequential stages of potentially harmful 
immune responses appropriate localisation of Tregs is indispensable for their function (Huehn and 
Hamann, 2005). However, the physiologic conditions, which may favour the peripheral development 
of distinct subsets of natural Tregs, remained elusive.  
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1.1.6 Peripheral maintenance of CD4+ Tregs 
One prerequisite for survival and function of Tregs in the periphery appears to be the presence of their 
respective antigen (Garza, et al., 2000; Jordan, et al., 2001; Nishikawa, et al., 2005; Seddon and 
Mason, 1999; Walker, et al., 2003). As the majority of Foxp3+ Tregs are selected towards high affinity 
recognition of self-antigen in the thymus, it is thought that the very antigen that caused their positive 
selection in the thymus activates them in the periphery. Consistent with this notion Tregs display 
remarkable proliferation in vivo, i.e. they respond to self-peptide presented by unique DCs in tissue-
draining lymph nodes (LN) (Cozzo, et al., 2003; Fisson, et al., 2003; Klein, et al., 2003; Walker, et al., 
2003; Yamazaki, et al., 2003). In addition, cytokines contribute to the maintenance of Tregs under 
steady state conditions. The growth factor IL-2 has been identified as the principle survival factor of 
peripheral Tregs. The pivotal role of this cytokine is delineated from studies showing that mice 
deficient for either IL-2 or the high affinity receptor IL-2R α-chain (CD25) develop generalised 
autoimmune diseases (Sadlack, et al., 1993; Sadlack, et al., 1995; Willerford, et al., 1995). Pathology 
is a consequence of dramatically reduced numbers of CD4+CD25+, reflecting the importance of IL-2 
signalling in maintenance of Treg homeostasis and function (Bayer, et al., 2005; D'Cruz and Klein, 
2005; Fontenot, et al., 2005; Furtado, et al., 2002; Setoguchi, et al., 2005). Furthermore, an essential 
role for TGF-β signalling has been identified for peripheral expansion, maintenance of Foxp3 
expression and suppressive function of Tregs (Huber, et al., 2004; Marie, et al., 2005). Thus, a 
complex interplay between different signals received under physiologic conditions controls the 
survival and function of Tregs in the periphery. 
 
1.1.7 Mucosal immune homeostasis 
Apart from responses to self-antigens, constant encounters with dietary and microbial antigens at 
mucosal surfaces require regulatory mechanisms, which also include the action of various intestinal 
Treg subsets (reviewed in (Mowat, 2003; Rook and Brunet, 2005)). This state of intestinal tolerance 
was demonstrated in several studies showing i.e. that under non-inflammatory conditions the response 
to bacterial antigen is actively suppressed. Intestinal T cells did not proliferate in response to 
enterobacterial antigens in vitro (Duchmann, et al., 1996; Gad, et al., 2004; Khoo, et al., 1997), 
however, depletion of CD4+CD25+ T cells (Gad, et al., 2004) or exposure to heterologous bacterial 
antigen (Duchmann, et al., 1996) reversed unresponsiveness in these cultures. In vivo break of 
tolerance towards the intestinal microflora is believed to be the major cause of inflammatory bowel 
disease (Duchmann, et al., 1995). The capacity of CD4+CD25+ Tregs to prevent such inflammatory 
responses in the intestine has been illustrated in numerous studies of experimental colitis and clearly 
demonstrates a pivotal role for Tregs in the maintenance of intestinal homestasis (reviewed in (Izcue, 
et al., 2006)).  
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Studies in germfree mice demonstrate a pivotal role for the commensal flora in the development of a 
tolerogenic microenvironment. First of all, the absence of microbial stimuli influences the 
development of mucosal and systemic lymphoid tissues. In germfree mice Peyer’s Patches (PP) are 
hypoplastic, IgA-secreting plasma cells and lamina propria CD4+ T cells are greatly reduced in 
numbers and structural defects also affect the spleen and peripheral LN (pLN). Colonisation of 
germfree mice with commensal flora from SPF mice is able to reverse these abnormalities 
(Macpherson and Harris, 2004). Furthermore, development of oral tolerance was dependent on a 
complex intestinal flora (Rask, et al., 2005) and previous exposure of Tregs to bacterial antigens was 
required for amelioration of experimental colitis (Strauch, et al., 2005).  
Recognition of pathogens by the Toll-like receptor (TLR) family is well documented (Medzhitov and 
Janeway, 2000). Commensal microorganisms equally express their respective ligands and therefore 
TLRs are similarly implicated to play a role under steady state conditions. Accordingly, absence of 
TLR signalling impaired normal gut epithelial homeostasis (Rakoff-Nahoum, et al., 2004) and 
increased allergic responses to food antigens (Bashir, et al., 2004). Some TLRs are selectively 
expressed by Tregs as compared to other T cells (Caramalho, et al., 2003) and particularly TLR2 was 
described to play a role for Treg proliferation both in vitro and in vivo (Liu, et al., 2006; Netea, et al., 
2005; Sutmuller, et al., 2006) 
These data provide good evidence to suggest that intestinal colonisation by commensal microbes may 
contribute to the continuation of immune homeostasis and protection from aberrant immune responses 
by providing various stimuli for expansion and maintenance of Tregs in the periphery.  
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1.2 Migration of T cells 
T cells continuously recirculate between blood and tissue in order to exert their immunologic function 
(Gowans and Knight, 1964). Depending on their state of differentiation and activation they follow 
different migratory routes and enter different types of tissue (Butcher and Picker, 1996). Naïve T cells 
preferentially migrate to secondary lymphoid organs including pLN, mesenteric LN (mLN), spleen 
and PP, which are the sites where they get activated if cognate antigen and co-stimulatory signals are 
present. Upon antigen-specific activation T cells proliferate, differentiate into effector/memory T cells 
and acquire the ability to migrate to non-lymphoid tissue and to sites of inflammation. 
In order to emigrate from the blood into lymphoid and non-lymphoid tissue T cells have to interact 
with specialised endothelial surfaces, either the high endothelial venules (HEVs) in secondary 
lymphoid tissue, such as LNs, or the postcapillary venules in non-lymphoid tissue. Molecules on the 
surface of T cells as well as molecules on the endothelium are involved in this interaction, which 
eventually leads to extravasation of T cells from the blood into tissue. 
 
1.2.1 The multistep model 
The process of transendothelial migration of T cells and other leukocytes can be divided into four 
sequential stages and many of the molecules that are involved in each step, have been identified 
(Butcher, 1991; Butcher, 1990; Springer, 1990; Springer, 1994). In the initial phase T cells are slowed 
down from the blood flow via labile interactions with the endothelial cells mediated by the selectin 
family and their ligands. Due to the particular adhesive strength of this interaction T cells do not come 
to a complete halt but roll along the vessel wall and sample the specific site for factors that can trigger 
their firm adhesion. The triggering or activation is mediated by chemokines, which are displayed on 
the luminal side of the endothelium. Binding to chemokine receptors on the surface of T cells leads to 
activation of integrins and subsequently to arrest and firm adhesion of the T cell to the vessel wall. 
The activation of integrins is required to allow high affinity binding to their ligands on the 
endothelium, which belong to the immunoglobulin (Ig)-superfamily. Firm adhesion is followed by 
transmigration of T cells through the endothelium into the tissue. Chemokines serve as chemotactic 
factors guiding the migration of T cells to their final destination within the tissue.  
 
1.2.2 Molecules involved in the transmigration cascade 
The selectin family of adhesion molecules contains three members termed E-selectin (CD62E), P-
selectin (CD62P) and L-selectin (CD62L). The family members share common structural features 
such as N-terminal Ca2+-dependent lectin homologous regions. These domains enable them to bind to 
carbohydrate ligands expressed on the surface of other cells (Springer, 1990). E- and P- selectin are 
expressed on endothelial cells, while L-selectin is exclusively expressed on lymphocytes.  
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The ligands for selectins are sialylated carbohydrate moieties, which are linked to mucin-like 
molecules. Mucins are heavily O-glycosylated serine- and threonine-rich proteins (Springer, 1994). 
Their glycosylation is dependent on the expression and activity of a family of enzymes, including 
α(1,3)-fucosyltransferases (FucT). Modification of the P-selectin glycoprotein ligand 1 (PSGL-1) by 
these enzymes is essential for the expression of functional ligands for P- and E-selectin (Maly, et al., 
1996). Another ligand for E-selectin, the cutaneous lymphocyte-associated antigen (CLA), is a 
specialised isoform of PSGL-1 and is involved in tissue specific migration of a subset of memory T 
cells (Fuhlbrigge, et al., 1997). Selectin/selectin ligand interactions display rapid “on” and “off” rates 
and provide labile adhesive interaction between leukocytes and endothelial cells. Thus they have been 
shown to have a role in the initial slowing of leukocytes from the blood flow (Springer, 1994). 
 
Integrins are a large family of versatile adhesion molecules. They are heterodimeric transmembrane 
proteins, containing non-covalently linked α and β subunits. At least 18 α chains and 8 β chains have 
been described forming at least 24 heterodimers. Integrins play a major role in cell adhesion to 
extracellular matrix proteins as well as in cell-cell interactions. They are pivotal in regulating adhesion 
and migration during development, wound healing and immune reactions (van der Flier and 
Sonnenberg, 2001). Integrins are grouped into several subfamilies, the β chain determining the family 
and the α chain determining the ligand specificity. T cells express β1, β2 and β7 heterodimers, 
respectively. The individual integrin pattern is subset-specific and depends on the state of 
differentiation. The β2 and α4 containing integrin hetrodimers are mainly involved in cell-cell 
interaction between leukocytes and other cells. The major cellular ligands for leukocyte integrins are 
found within the Ig superfamily. Family members involved in the leukocyte-endothelial interaction, 
include intercellular adhesion molecule 1 (ICAM-1), ICAM-2, vascular cell adhesion molecule 1 
(VCAM-1), and mucosal addressin cell adhesion molecule 1 (MAdCAM-1). A characteristic feature 
of these transmembrane C2-type proteins is the presence of a variable number of Ig-like domains. 
MAdCAM-1 is unique in that it also contains a mucine-like region, which makes it a dual ligand both 
for the integrin α4β7 as well as for L-selectin. The expression of the above Ig superfamily members on 
endothelial cells is either constitutive or upregulated upon stimulation with inflammatory cytokines, 
such as tumor necrosis factor-α (TNF-α) (Carlos and Harlan, 1994; Springer, 1994). The distinct 
pattern of adhesion molecules expressed on the surface of endothelial cells is one level of regulating 
the selective recruitment of leukocytes across the endothelial cell layer. 
 
Chemokines are small chemoattractant cytokines that can be classified according to NH2-terminal 
cysteine motifs. Four subfamilies are recognised comprising C, CC, CXC and CX3C chemokines. The 
C and CX3C subfamilies contain only one family member. The CC subfamily currently comprises 28 
members and the CXC subfamily 16 members. Based on a more functional classification chemokines 
are grouped into “inflammatory” (also called inducible) or “homeostatic” (also termed constitutive) 
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chemokines. Inflammatory chemokines play a crucial role in the recruitment of various effector cells 
to sites of inflammation. They are produced and secreted by resident or infiltrating cells in the 
inflamed tissue upon pathogen contact or activation with pro-inflammatory cytokines (Moser and 
Loetscher, 2001). The constitutive chemokines on the other hand maintain physiological trafficking of 
leukocytes and are usually produced in a distinct microenvironment, e.g. lymphoid tissue or skin and 
mucosa. They are mainly involved in hematopoiesis, antigen sampling and immune surveillance 
(Moser and Loetscher, 2001). However, the division of chemokines into either group is not absolute, 
as several chemokines show overlapping functions.  
Chemokines exert their functions via binding to a family of surface receptors, which are seven 
transmembrane domain G-protein-coupled receptors. Most chemokine receptors are promiscuous and 
bind more than one chemokine ligand. However, CC chemokines only bind to CC receptors and CXC 
chemokines only to CXC receptors. The expression of chemokine receptors is dependent on the state 
of differentiation and activation. Naive T cells, as a rather homogenous population express limited 
numbers of chemokine receptors. Upon antigen-specific activation the chemokine receptor pattern 
changes. Differential expression has been described for Th1 and Th2 effector T cells linking the 
distinct combination of chemokine receptor expression to differential functional properties (Sallusto, 
et al., 1998).  
The main function of chemokines and their receptors is the control of leukocyte trafficking. They have 
a major role in the promotion of leukocyte migration along chemotactic gradients and in activation of 
integrins, thereby inducing adhesion of leukocytes to other cells and components of the extracellular 
matrix (Moser and Loetscher, 2001).  
 
1.2.3 Organ-selective migration 
Differential expression and distinct distribution of the molecules involved in each sequential step of 
transendothelial migration, provide the basis for the high level of specificity that is required to control 
T cell trafficking. Both, T cells and endothelium, contribute to this specificity. An area code model has 
been proposed, that allows specific targeting of circulating T cells based on the combination of three 
sequential interactions mediated by selectin/selectin ligand, chemokine/chemokine receptor and 
integrin/ligand binding. An important feature is that these interactions occur in sequence and not in 
parallel. Multiple receptors and ligands within each group provide the molecular basis for a large 
combinatorial diversity in regulating T cell migration (Butcher, 1991; Springer, 1994).  
 
1.2.3.1 Migration and homing of naïve T cells to lymphoid tissue 
The combined expression of the selectin family member CD62L (or L-selectin) and the chemokine 
receptor CCR7 mediates selective migration of naïve T cells to secondary lymphoid organs. The 
endothelial ligands for CD62L include glycosylation-dependent cell-adhesion molecule-1 
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(GlyCAM-1) and CD34, which are expressed on pLN HEVs, and MAdCAM-1 on intestinal HEVs. 
They all carry the peripheral lymph node addressin (PNAd) carbohydrate epitope, which mediates 
interaction with CD62L on T cells (Patel, et al., 2002). Trafficking of naïve T cells to gut-associated 
lymphoid tissue (GALT), such as mLN and PP, is controlled additionally by low-level expression of 
the integrin α4β7. Rolling on PP HEVs and to a lesser extent on mLN HEVs, is supported by 
interaction of α4β7 with MAdCAM-1 (Berlin, et al., 1995). The CCR7 ligand, CCL21, is expressed by 
HEVs (Gunn, et al., 1998) and triggers activation of LFA-1- or α4β7-mediated adhesion to endothelial 
ligands (Hamann, et al., 1988). Within the LN chemotactic gradients of the other CCR7 ligand CCL19 
ensure proper localisation of naïve T cells to the T cell zone, where they can interact with antigen-
presenting cells (APCs).  
 
1.2.3.2 Migration and homing of effector/memory T cells to non-lympoid tissue 
In contrast to the uniform homing properties displayed by naïve T cells, the pool of circulating 
effector/memory T cells contains distinct subsets exhibiting tissue-selective homing behaviour. 
Migration to GALT, the small intestinal lamina propria and the mucosal epithelium is mediated by the 
integrin α4β7 (Hamann, et al., 1994; Holzmann and Weissman, 1989). The principal endothelial ligand 
of α4β7, MAdCAM, is almost exclusively expressed on mLN and PP HEVs and postcapillary venules 
in the intestinal lamina propria (Berlin, et al., 1993; Nakache, et al., 1989; Streeter, et al., 1988). This 
differential expression pattern provides the basis for selective recruitment of effectory/memory T cell 
subsets expressing high levels of α4β7. In addition, expression of the chemokine receptor CCR9 has 
been identified on a fraction of circulating α4β7+ T cells (Kunkel, et al., 2000; Zabel, et al., 1999) and 
on the majority of freshly isolated small intestinal lamina propria lymphocytes (Papadakis, et al., 
2000), consistent with high expression levels of the CCR9 ligand CCL25 by epithelial cells of the 
small intestine and in lamina propria venules (Papadakis, et al., 2000). Thus, expression of these two 
homing receptors defines gut-tropic effector/memory T cells.  
In contrast, T cell trafficking to the skin is mediated by P-selectin ligands (P-Lig) and E-selectin 
ligands (E-Lig) (Picker, et al., 1990; Picker, et al., 1991; Tietz, et al., 1998) as well as CCR4 and 
CCR10 (Campbell, et al., 1999; Homey, et al., 2002; Reiss, et al., 2001). Expression of E-selectin and 
P-selectin on skin venules is constitutive (Weninger, et al., 2000) in contrast to other vascular 
endothelium, where they are transiently expressed in response to inflammatory signals (Bevilacqua, et 
al., 1987; Gotsch, et al., 1994). Similarly, the ligands for CCR4 (CCL17) and CCR10 (CCL27) are 
found on inflamed and non-inflamed skin endothelium (Campbell, et al., 1999; Homey, et al., 2002).  
These two examples of peripheral tissue sites are the best studied to date and undermine the principle 
of organ-selective migration (Figure 1). 
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Figure 1: The multistep model in organ-selective trafficking of T cells 
Sequential steps of transendothelial migration of T cells and the postulated adhesion molecules and 
chemokines/chemokine receptors involved in homing of naïve T cells, skin-specific and gut-specific 
effector/memory T cells, respectively. See text for details (1.2.1 and 1.2.3) (adapted from Campbell and Butcher 
(Campbell and Butcher, 2000)). 
 
 
1.2.4 Regulation of organ-specific migration  
Accumulating evidence suggests that the site of antigen presentation predicts the homing phenotype of 
the activated T cells. Early studies already indicated that activated lymphocytes isolated from the 
intestinal or cutaneous lymphoid tissue homed preferentially to their tissue of origin upon adoptive 
transfer (Griscelli, et al., 1969; Hall, et al., 1977). More recently, a number of studies have described 
that antigen-dependent differentiation of naïve T cells in lymphoid organs leads to the generation of 
effector T cells exhibiting a capacity to enter peripheral non-lymphoid tissue (Kunkel and Butcher, 
2002). Effector T cells generated in different lymphoid organs display distinct tissue tropism, which is 
regulated by an organ-specific induction of adhesion molecules and chemokine receptors during T cell 
priming (Calzascia, et al., 2005; Campbell and Butcher, 2002; Dudda and Martin, 2004; Dudda, et al., 
2004; Johansson-Lindbom, et al., 2003; Mora, et al., 2003; Stagg, et al., 2002; Svensson, et al., 2002). 
For example, T cells activated in mLN and PPs draining the gut acquire high levels of the integrin 
α4β7, whereas activation in skin-draining pLN results in the up-regulation of selectin ligands such as 
P-Lig. Tissue-specific DCs have been shown in a number of in vitro and in vivo studies to be involved 
in the instruction of naïve T cells (Annacker, et al., 2005; Dudda and Martin, 2004; Dudda, et al., 
2004; Johansson-Lindbom, et al., 2005; Johansson-Lindbom, et al., 2003; Mora, et al., 2003; Mora and 
von Andrian, 2006; Stagg, et al., 2002).  
Recently, Iwata et al. reported that gut-associated lymphoid tissue DCs were capable of converting 
metabolites of dietary vitamin A into retinoic acid (RA), which in turn induced T cell expression of 
α4β7 and CCR9 leading to the generation of gut-tropic T cells (Iwata, et al., 2004). In contrast, the 
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factors involved in the generation of skin-specific T cell homing in vivo, are largely unknown, 
although important roles for cytokines including IL-12 and TGF-β have been suggested from in vitro 
studies (Austrup, et al., 1997; Lim, et al., 1999; Wagers and Kansas, 2000). On the T cell side, 
induction of functional P/E-Lig depends on expression of the enzyme FucT-VII, which in turn is up-
regulated upon TCR stimulation and further enhanced by the presence of IL-12 (White, et al., 2001).  
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1.3 Aims and objectives 
Our group has previously shown that the markers αE and CD25 allow subdivision of the murine CD4+ 
Treg compartment into naïve-like and effector/memory-like Treg subsets. αE-expression identifies 
Tregs with an activated state that have undergone repetitive rounds of proliferation indicative of 
antigen-specific expansion or differentiation in the periphery. The effector/memory phenotype of αE+ 
Tregs enabled recruitment of these Treg subsets into peripheral sites of inflammation, whereas naïve-
like αE- Tregs preferentially migrated to secondary lymphoid organs. Ultimately, these distinct 
characteristics were directly coupled to the functional activity of the respective subsets in vivo, 
indicating that appropriate localisation was a prerequisite for suppressive capacity. These results 
initiated the hypothesis that there exists division of labour between distinct subsets of naturally 
occurring Tregs. However, physiologic conditions, which support peripheral development of distinct 
subsets of natural Tregs, had not been identified. Moreover, it was not clear whether αE+ Tregs 
originate from naïve-like αE-CD25+ Tregs differentiating into an effector/memory phenotype upon 
antigen-driven activation and proliferation, or whether αE+ Tregs can also directly develop from naïve 
T cells under appropriate, tolerogenic conditions. In the present study in vivo proliferation of various 
subsets of CD4+ Tregs under homeostatic conditions was analysed and the influence of commensal 
microflora on homeostatic proliferation of CD4+ Tregs was investigated. Furthermore, activation and 
differentiation of TCR-tg T cells in response to oral feeding of cognate antigen were examined in an 
adoptive transfer model.  
An additional aim of the current study was to investigate how Tregs acquire the expression of homing 
receptors needed for tissue- or inflammation-specific migration. Although homing receptors known 
from conventional T cells were also found on Tregs, it was unknown, whether they respond in a 
similar way as conventional naïve T cells to signals instructing tissue-specific homing receptor 
expression and organ-selective trafficking. The present study focused on the induction of gut- and 
skin-specific trafficking patterns on Tregs. The susceptibility of naïve Tregs to acquire homing 
receptor expression under defined in vitro culture conditions was investigated and the functionality of 
the induced phenotype was tested upon adoptive transfer.  
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2 Materials and Methods 
2.1 Material 
2.1.1 Material and Reagents 
all-trans-Retinoic acid (RA) Fluka BioChemika, Buchs, Schwitzerland 
β-Mercaptoethanol Invitrogen, Karlsruhe 
Bovine Serumalbumin (BSA, Fraction V) Fluka BioChemika, Buchs, Schwitzerland 
Bromodeoxyuridin (BrdU) Sigma-Aldrich, Taufkirch 
Calliper “Oditest-Schnelltaster”  Kröplin, Schlüchtern 
5-Carboxy-fluorescein diacetate succinimidyl ester 
(CFSE) 
Moleculare Probes, Eugene, USA 
Cell strainer, 70 µm Beckton Dickinson Labware, Franklin Lakes, NJ, USA 
Collagenase D Roche Diagnostic, Mannheim 
Culture dishes, various sizes Greiner, Nürtingen 
Corning Inc., NY, USA 
Diamidinophenylindol (DAPI) Sigma-Aldrich, Taufkirch 
DNase I Sigma-Aldrich, Taufkirch 
Ethylendiaminetetraacetic acid (EDTA) Sigma-Aldrich, Taufkirch 
Fetal calf serum (FCS) 
inactivated for 30 min at 56°C 
Sigma-Aldrich, Taufkirch 
Fluoresbrite microspheres, 20 µm Polyscience Inc., Warrington, PA, USA 
Gentamycin Biochrome AG, Berlin 
Hanks balanced salt solution (HBSS) Biochrome AG, Berlin 
Hydroxyethylpiperazine ethanesulfonic acid (HEPES) Biochrome AG, Berlin 
Incomplete Freud’s Adjuvant (IFA) Sigma-Aldrich, Taufkirch 
111Indiumoxin  Amersham Biosciences, Freiburg 
Lipopolysaccharide (LPS), from  E. coli serotype 
055:B5 
Sigma-Aldrich, Taufkirch 
MACS MicroBeads and MultiSort reagents Miltenyi Biotec GmbH, Bergisch Gladbach 
MACS® Pre-Separation Filter Miltenyi Biotec GmbH, Bergisch Gladbach 
MidiMACS™ Separator and MACS® Separation 
columns LS and MS 
Miltenyi Biotec GmbH, Bergisch Gladbach 
Mycojector-Syringe U40 BSNmedical, Eschborn 
Neubauer haemocytometer Paul Marienfeld GmbH & Co. KG, Lauda 
Nycodenz Nyegaard, Oslo, Norway 
Ovalbumin peptide (OVA323-339) 
Sequence: 323ISQAVHAAHAEINEAGR339 
Institut für Biochemie, Humboldt-Universität zu Berlin 
Ovalbumin (OVA) protein, Grade V Sigma-Aldrich, Taufkirch 
Penicillin-Streptomycin Biochrome AG, Berlin 
Phosphate buffered salt solution (PBS) PAA Laboratories, Pasching, Austria 
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Propidium Iodide (PI) Sigma-Aldrich, Taufkirch 
Rat Immunoglobulin (IgG)  Jackson ImmunoResearch Laboratories, West Grove, 
PA, USA 
Recombinant murine cytokines 
IL-12, IFN-γ, IL-2 
R&D Systems, Wiesbaden 
Rosewell Park Memorial Institute Medium  
(RPMI 1640) with GlutamaxI 
Invitrogen, Karlsruhe 
Sodium Pyruvate Gibco, Karlsruhe 
Syringes and needles  Braun-Melsungen, Melsungen 
Trypanblue Sigma-Aldrich, Taufkirch 
 
2.1.2 Buffers and Media 
Complete Medium RPMI 1640, 25 mM HEPES, 10% FCS,  
50 µM β-Mercaptoethanol, 1 mM Sodium-Pyruvat,  
100 U/ml Penicillin, 100 U/ml Streptomycin,  
50 µg/ml Gentamycin 
Phosphate-buffered salt solution (PBS) 8 g/L NaCl, 0.2 g/L KH2PO4, 1.4 g/L Na2PO4 · H2O 
PBS/BSA PBS, 2 g/L BSA 
HBSS/BSA HBSS, 2 g/L BSA 
Erythrocyte-Lysing-Buffer 10 mM KHCO3, 155 mM NH4Cl,  
0.1 mM EDTA, pH 7.5 
 
2.1.3 Instruments 
autoMACS™ Separation unit Miltenyi Biotec GmbH, Bergisch Gladbach 
CO2 -Incubator Binder, Tuttlingen 
  Flow cytometer: 
BD FACSDiva™, BD FACSAria™,  
BD FACSCalibur™, BD LSRII™ 
 
Beckton Dickinson, Heidelberg 
 
γ-Irradiator Biobeam 2000 STS Steuerungstechnik&Strahlenschutz GmbH, 
Braunschweig 
γ-counter Wallac, Turku, Finland 
Laminar-Flow-Bench HERAsafe Heraeus Instruments, Hanau 
Microscope Helmut Hund GmbH, Wetzlar 
  Centrifuges: 
Biofuge fresco, Biofuge 28 RS,  
Megafuge 1.0R 
 
Heraeus Instruments, Hanau 
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2.1.4 Staining reagents and antibodies for flow cytometry  
Table 1: Antibodies and reagents used for fluorescent labelling of lymphocytes 
Specificity  Clone Isotype Fluorochrome/Hapten Origin 
Mouse CCR9 242503 Rat IgG2b PE R&D Systems 
GK1.5 Rat IgG2b FITC, Alexa 405 DRFZ Mouse CD4 
RM4-5 Rat IgG2a FITC, PerCP, Pacific Blue BD Biosciences 
Mouse CD11c N418 Hamster IgG PE DRFZ 
Mouse CD16/CD32  2.4G2 Rat IgG2b pure DRFZ 
PC6.1 Rat IgG1 APC, PerCP-Cy5.5 BD Biosciences Mouse CD25 
7D4 Rat IgM FITC, Biotin BD Biosciences 
Mouse CD44 IM7 Rat IgG2b Biotin DRFZ 
Mouse CD62L /  
L-Selectin 
MEL-14 Rat IgG2a FITC, Biotin DRFZ 
M290 Rat IgG2a PE BD Biosciences Mouse CD103 /  
Integrin αE   Alexa 647, Biotin DRFZ 
Mouse Integrin α4β7  DAKT32 Rat IgG2a PE, Biotin BD Biosciences 
Mouse Foxp3 FJK-16s Rat IgG2a FITC, PE eBioscience 
Mouse OVA TCR KJ1.26 Rat IgG2a Biotin, Cy5 DRFZ 
BrdU n.d. n.d. FITC BD Bioscience 
Biotin  Streptavidin PE, PE-Cy7 BD Bioscience 
Human IgG (H+L) polyclonal F(ab’)2 donkey 
F(ab’)2 mouse 
PE 
Cy5 
Jackson 
ImmunoResearch 
Human IgM (H+L) polyclonal Rabbit Biotin Jackson 
ImmunoResearch 
Mouse  
P-selectin ligand (P-Lig) 
Fusion-protein consisting of mouse P-selectin and human IgG 
Fc fragment 
DRFZ, 
BD Bioscience 
Mouse  
E-selectin ligand (E-Lig) 
Fusion-protein consisting of mouse E-selectin and human IgM 
Fc fragment 
John Lowe, 
Daniel J. Campbell 
 
2.1.5 Mice 
BALB/c Bundesinstitut für Risikobewertung, Berlin 
DO11.10 Bundesinstitut für Risikobewertung, Berlin 
C57BL/6 Bundesinstitut für Risikobewertung, Berlin and 
Forschungseinrichtung für experimentelle Medizin (FEM), Charité, Berlin 
C57BL/6, thymectomised kindly provided by L. Klein 
Institute of Molecular Pathology, Vienna, Austria 
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2.2 Methods 
2.2.1 Isolation of lymphocytes from mouse tissue 
Spleen and various LNs were removed from mice killed by cervical dislocation. As skin-draining 
pLNs cervical, mandibular (neck), brachial, axilial (arm pit) and inguinal LNs were pooled. 
Furthermore, gut-draining mLN and liver-draining celiac LN (livLN) were usually pooled. To obtain a 
single cell suspension, spleen and LNs were cut into small pieces with surgical scissors and mashed 
through steel or nylon sieves in HBSS/BSA using a syringe plunger. Centrifugation of cell 
suspensions was performed at 300 x g and 4°C for 8-10 min, unless otherwise stated. Erythrocytes 
were lysed by incubating the cell suspension in cold Erythrocyte-Lysing buffer for 2-3 min at room 
temperature (RT). Subsequently, cells were washed twice with PBS/BSA and stored on ice until 
further use. Lymphocytes were counted in a haemocytometer in the presence of trypanblue to exclude 
dead cells. 
 
2.2.2 Isolation of lymphocyte subsets by MACS and FACS 
In order to isolate specific subpopulations from the heterogeneous lymphocyte population two 
methods were used, both based on specific labelling of surface molecules with monoclonal antibodies 
(mAbs). For magnetic cell sorting (MACS) mAbs coupled to 50 nm sized paramagnetic MicroBeads 
(Miltenyi Biotec) were used. The labelled cell suspension was applied to a steel column in a magnetic 
field. Thereby magnetically labelled cells were retained on the column in the magnetic field, while 
unlabelled cells were washed out in the flow through. In the following, removal of the column from 
the magnetic field allowed elution of the magnetically labelled cells from the column (Miltenyi, et al., 
1990). The actual separation was performed either manually with single-use steel columns (LS and 
MS columns, Miltenyi Biotec) operated by gravity flow or by using an automated separation unit 
(autoMACS, Miltenyi Biotec) with standardised flow rates. Separation via the autoMACS allowed 
further fine tuning of the separation process by using different flow rates for optimised retention of 
weakly labelled cells at low flow or increased purity by higher flow and sequential separation via two 
columns. By combining different sorting strategies of depletion/removal of unwanted cells and 
enrichment of wanted cells by positive selection, MACS enabled isolation of cells according to a 
maximum of three parameters. One major advantage of the MACS technology is the processing of 
large cell numbers at one time i.e. up to 2 x 109 lymphocytes per autoMACS separation. 
For fluorescence-activated cell sorting (FACS) fluorochrome-coupled mAbs were used for labelling of 
the cells. Similar to analytic flow cytometric analysis, stained cells are taken up via a sample port and 
transported to the flow chamber where they pass a laser beam of defined wavelength. The process of 
hydrodynamic focussing ensures that cells are lined up one by one and pass the laser as a stream of 
single cells. The excited fluorochromes on the labelled cells emit light according to their distinct 
physical properties, which is detected by specific detectors (photomultiplier tube, PMT). After passage 
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through the flow chamber the stream of cells is separated into single droplets by vibration of the 
nozzle. Statistically, each droplet contains a single cell and subsequently receives an electric charge. 
These charged droplets are deflected in an electric field and sorted separately into individual sample 
tubes. The charge of the droplet and thereby the sorting is set according to the parameters assigned by 
the operator and represents the labelling of the cells with a specific fluorochrome (Goettlinger, et al., 
1999; Goettlinger, et al., 1999). Thereby, labelled cells can be separated from unlabelled cells. Using 
the FACSAria (BD Bioscience) up to 4 different cell subsets can be sorted at the same time. This 
method is particularly useful in order to sort subpopulations of cells, which can only be identified by 
combinations of several surface markers. However, one disadvantage is the fact that only up to 1 x 108 
cells can be sorted per hour.  
By combining both methods, MACS and FACS, it was possible to isolate even very small 
subpopulations of lymphocytes to high purity. 
 
2.2.2.1 Isolation of naïve CD4+ T cells  
Single cell suspensions from pooled LNs and spleen were obtained as described above (2.2.1). In 
order to block unspecific binding of mAbs to Fc receptors on lymphocytes, anti-Fcγ receptor II/III 
mAb was added to the cell suspension at a final concentration of 20 µg/ml. Cells were stained with 
anti-CD4-FITC at a cell density of 2 x 108 cells/ml for 10 min at 6-12° C. Unbound mAb was removed 
by washing the cell suspension with at least 10-fold excess volume of PBS/BSA. Subsequently cells 
were labelled with anti-FITC MultisortBeads (Miltenyi Biotec) at a cell density of 2 x 108 cells/ml for 
15 min at 6-12° C. Unbound MultisortBeads were removed by washing as described above. CD4+ T 
cells were isolated using the autoMACS (program: PosselD2). In order to remove the magnetic label 
Release Reagent (Miltenyi Biotec) was added to the positive fraction and incubated for 10 min at 6-
12°C and 20 min at RT. The cell suspension was re-applied to the autoMACS separator (Deplete) and 
non-magnetic CD4+ T cells were collected in the negative fraction. Subsequently CD4+ T cells were 
labelled with anti-CD62L MicroBeads and naïve CD4+CD62Lhigh T cells were purified on the 
autoMACS (PosselD2). Purity of the enriched cells was confirmed by flow cytometry and was usually 
about 98%. Naïve CD4+CD62Lhigh T cells were used for generation of Th1 cells (2.2.4.1). 
In some experiments CD25-CD4+CD62Lhigh T cells were required. Therefore, CD25+ cells were 
removed from the initial cell suspension by magnetic labelling with anti-CD25-APC and anti-APC 
MicroBeads and subsequent sensitive separation on the autoMACS (DepleteS). From the remaining 
CD25- fraction naïve CD4+CD62Lhigh cells were isolated as described above. CD25-CD4+CD62Lhigh 
cells were used as responder cells in in vitro proliferation assays (2.2.4.2). 
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2.2.2.2 Isolation of αE- lymphocytes for adoptive transfer  
Single cell suspensions from lymphoid organs of DO11.10 mice were labelled with anti-αE-PE and 
anti-PE MicroBeads and αE+ cells were depleted using the sensitive mode of the autoMACS 
(Deplete05). The αE- fraction was collected and labelled with biotinylated anti-CD25 and anti-Biotin 
MicroBeads. In the next step the cell suspension was separated into CD25+ and CD25- cells on the 
autoMACS (DepleteS). While the negative fraction was used for isolation of naïve CD25- cells using 
anti-CD62L MicroBeads, the positive fraction was re-applied to the autoMACS (PosselD2) in order to 
improve the purity of CD25+ Tregs. For adoptive transfer cells were not purified according to CD4 
expression in order to minimise sample handling and cell loss. The actual number of transferred CD4+ 
T cells was calculated from the total transferred lymphocyte count according to the frequency of CD4+ 
T cells measured by flow cytometry. For adoptive transfer sorted cells were washed and resuspended 
in PBS. Purified αE-CD25+ Tregs and αE-CD25-CD62Lhigh cells from DO11.10 mice were used for 
antigen-specific activation in vivo (2.2.5.3). 
 
2.2.2.3 Isolation of naïve CD4+ T cell subsets for homing receptor induction in vitro  
Naïve CD4+CD25+ Tregs were isolated by a combination of MACS and FACS sorting from cell 
suspensions of pooled LNs and spleens from DO11.10, BALB/c or C57Bl/6 mice. Single cell 
suspensions were prepared as described in 2.2.1 and labelled with anti-CD25-FITC and anti-FITC 
MicroBeads followed by magnetic pre-enrichment of CD25+ T cells using the autoMACS (PosselS). 
For isolation of naïve CD4+CD25+ Tregs, the positive fraction was stained with anti-CD4-PerCP and 
anti-CD62L-APC and CD4+CD25+CD62Lhigh Tregs were sorted by FACS (FACSAria) to a purity of 
>96%. Sorted cells were resuspended in complete medium and used for in vitro culture under various 
conditions (2.2.4.3 and 2.2.4.4).  
In some experiments CD4+CD25-CD62Lhigh T cells were also sorted from the remaining cell 
suspension. Therefore, the negative fraction of the magnetic CD25+ enrichment was labelled with anti-
CD4 MicroBeads and CD4+CD25- T cells were isolated by autoMACS separation (PosselD2). The 
positive fraction was stained with anti-CD4-PerCP and anti-CD62L-APC and purified by FACS 
sorting into CD4+CD25-CD62Lhigh T cells. Sorted cells were resuspended in complete medium and 
used for in vitro culture under various conditions (2.2.4.3 and 2.2.4.4). 
 
2.2.2.4 Isolation of tissue-specific DCs for homing receptor induction in vitro  
Tissue-specific dendritic cells (DC) were isolated from pLNs and mLNs, respectively. LNs were cut 
into pieces and incubated in medium containing 1 mg/ml Collagenase D (Roche Diagnostics) and 
50 µg/ml DNaseI (Sigma Aldrich) for 30 minutes at 37°C. Subsequently, the digested tissue was 
passed through 70 µm cell strainers into PBS/BSA and cells were washed twice with PBS/BSA. DCs 
were labelled with anti-CD11c MicroBeads (Miltenyi Biotec) and magnetically enriched on two 
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consecutive columns (combination of LS and MS or autoMACS “PosselD2”). Purity of CD11c+ DCs 
was confirmed by flow cytometric analysis and was typically around 80%. Isolated DCs were washed 
and resuspended in complete medium. Tissue-specific CD11c+ DCs were used for induction of organ-
specific homing receptors on naïve CD4+CD25+ Tregs in vitro (2.2.4.3). 
 
2.2.3 Flow cytometric analysis of lymphocytes 
Lymphocytes stained with fluorochrome-labelled Abs as described in 2.2.3.1 were analysed on 
FACSCalibur or LSRII flow cytometers (BD Bioscience). Multicolour analysis and phenotyping was 
almost exclusively done on the LSRII, which is equipped with 3 lasers (violet diode 405 nm, Argon 
488 nm, HeNe 633 nm) and allows simultaneous detection of 8 fluorescent parameters in addition to 
forward scatter (FCS) and side scatter (SSC) signals (Tabel 2).  
 
Tabel 2: Configuration of LSRII flow cytometer (laser, optical filter set up and parameters) 
LSRII Longpass filter (nm) Bandpass filter (nm) Parameter/Fluorochrome 
Blue Laser (488nm) 735 780/60 PE-Cy7 
 685 695/40 PerCP-Cy5.5 
 635 670/14 PerCP, PE-Cy5 
 550 575/26 PE 
 505 539/30 FITC 
 - 488/10 SSC 
Red Laser (633 nm) 735 780/60 APC-Cy7 
 - 660/20 APC, Alexa 647, Cy5 
Violet Laser (405 nm) 505 525/50 DAPI  
 - 444/40 Alexa 405, Pacific Blue 
 
 
Combination of many fluorochromes requires careful compensation in order to minimise spectral 
overlap into neighbouring channels. The Diva Software is operated in digital mode, which allows 
compensation and potential correction of already acquired data. In order to set up a compensation 
matrix, single stained samples were prepared with each of the fluorochromes used in the respective 
experiment. Unstained cells and the single stained compensation samples were run on the instrument 
and compensation was either performed by using the automatic compensation tool of the Diva 
software or manually by the following method: the fluorochrome of interest was depicted in a dot plot 
vs. SSC. Regions were drawn on unstained and positively stained cells, respectively (Figure 2a). 
Using the statistics tool, the medians of the two populations were retrieved for all other fluorescent 
channels (Figure 2b). Spectral overlap was corrected in the compensation matrix until the median of 
the stained cells corresponded to the median of the unstained cells in the respective channel (Figure 
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2c). This was repeated for all other fluorochromes and the achieved compensation values combined 
for the multicolour acquisition of the actual stained samples and the appropriate controls. 
 
 
Figure 2: Manual compensation of single stained samples using Diva software on LSRII 
In order to set up proper compensation single stained samples of each fluorochrome were run on the LSRII. Each 
sample was depicted separately and spectral overlap into other channels corrected based on the median 
fluorescence intensity of unstained vs. stained cell subsets. (a) Representative dot plots of a FITC single stained 
sample. Lymphocytes were gated according to FSC and SSC properties and the gated cells were depicted in a new 
dot plot displaying SSC vs. FITC. Regions were drawn on unstained (P2) and stained (P3) populations, 
respectively. (b) Statistics were generated from the dot plot shown in (a) displaying the median of unstained and 
stained cells in all fluorescent channels. (c) Compensation was applied to each channel until the median of stained 
cells reached the median of unstained cells in each channel. 
 
Analysis of the data files was done using the CellQuest Software (BD Bioscience). Fluorescent minus 
one controls (FMOC) were used in order to set the appropriate gate for the analysis of the stained 
samples (Roederer, 2001). FMOCs contained all fluorochrome-labelled antibodies except one, so that 
the spectral background/influence of expression of any other marker could be evaluated for the 
parameter of interest. Results of the FACS analysis were expressed either as frequency of positive 
cells of the marker of interest or as the geometric mean fluorescent intensity (GMFI) of the marker of 
interest.  
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2.2.3.1 Fluorescent labelling of surface molecules on lymphocytes  
Lymphocytes were phenotyped by labelling with fluorochrome-coupled Abs directed against specific 
surface molecules followed by flow cytometric analysis of the stained cells. Single cell suspensions 
prepared as described in 2.2.1 or cultured cells were resuspended in 50 – 100 µl of PBS/BSA. In order 
to block unspecific binding of mAbs to Fc receptors on lymphocytes anti-Fcγ receptor II/III mAb was 
added to the cell suspension at a final concentration of 20 µg/ml. Antibodies directed against surface 
molecules were added at previously pre-determined titers and the suspension was incubated for 10 to 
20 minutes at 6-12° C. Most of the Abs were directly coupled to fluorochrome molecules (Table 1), 
those conjugated to biotin were detected by fluorochrome-labelled streptavidin as secondary reagent. 
For staining of functional P-selectin ligands (P-Lig) and E-selectin ligands (E-Lig) on lymphocytes, 
fusion-proteins consisting of mouse P-selectin and human IgG heavy chain or mouse E-selectin and 
human IgM heavy chain were used (kindly provided by D. Vestweber and J. Lowe, respectively). 
Importantly, binding of the chimera depended on the presence of Mg2+ and Ca2+ and therefore the 
complete staining procedure was performed in HBSS/BSA. Binding of P-selectin was detected by 
fluorochrome-labelled anti-human IgG (Jackson ImmunoResearch) and binding of E-selectin by 
biotinylated anti-human IgM (Jackson ImmunoResearch) and fluorochrome-labelled streptavidin. 
Unbound Abs and secondary reagents were removed by washing the cell suspension with at least 10-
fold excess volume of PBS/BSA or HBSS/BSA. Cells were then analysed by flow cytometry and 
DAPI or PI were added directly before acquisition to exclude dead cells.  
 
2.2.3.2 Intracellular labelling of Foxp3 
Intracellular staining for Foxp3 was performed using the anti-rat/mouse Foxp3 staining set from 
eBioscience, containing all required buffers and fluorochrome-labelled anti-Foxp3 mAb. Staining was 
done according to the manufacturer’s protocol with minor modifications. Briefly, upon staining for 
surface molecules as described above, up to 5 x 106 cells were resuspended in 500 µl eBioscience 
fixation buffer and incubated for 1 to 24 h at 6-12° C. The cell suspension was centrifuged and the cell 
pellet washed once with 1 ml of eBioscience permeabilisation solution. In order to block unspecific 
binding, cells were resuspended in 25 µl eBioscience permeabilisation solution containing rat IgG 
(Jackson ImmunoResearch) at a final concentration of 10 µg/ml. After 15 min at 6-12° C, 25 µl of 
fluorochrome-labelled anti-Foxp3 mAb diluted in eBioscience permeabilisation solution were added 
to a final concentration of 2 µg/ml mAb and the cells were incubated for another 30 min at 6-12° C. 
Unbound mAb was removed by washing the cell suspension with 1 ml of eBioscience 
permeabilisation solution. Cells were resuspended in PBS/BSA and analysed by flow cytometry.  
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2.2.3.3 Intracellular staining of BrdU 
Incorporation of Bromodeoxyuridine (BrdU) (2.2.5.1) was detected by using the BrdU Flow Kit (BD 
Bioscience) according to the manufacturer’s instructions with minor modifications. All reagents 
required for intracellular staining were supplied in the Kit. Surface staining was performed on single 
cell suspensions as described above (2.2.3.1) and 1 - 10 x 106 cells were fixed in 200 µl of BD 
Cytofix/Cytoperm buffer for 20 min at RT. Cells were washed with 1 ml of BD Perm/Wash buffer. 
Fixed cells were resuspended in 100 µl of BD Cytoperm Plus buffer for 10 min on ice. The suspension 
was washed with 1 ml of BD Perm/Wash buffer and fixed again in 100 µl of BD Cytofix/Cytoperm 
buffer for 5 min at RT. Following another wash with 1 ml of BD Perm/Wash buffer the cells were 
resuspended in 65 µl of DNAseI solution (300 µg/ml) and incubated for 1 h at 37° C, in order to make 
the DNA accessible for detection of incorporated BrdU by a specific mAb. The incubation was 
stopped by washing with 1 ml of BD Perm/Wash buffer. Finally, intracellular staining was performed 
with FITC-labelled anti-BrdU mAb diluted 1 to 50 in BD Perm/Wash buffer for 20 min at RT. 
Unbound mAb was removed by washing with 1 ml of BD Perm/Wash buffer, cells were resuspended 
in PBS/BSA and analysed by flow cytometry. In some experiments BrdU detection was combined 
with intracellular staining for Foxp3. Therefore, PE-labelled anti-Foxp3 mAb (clone FJK-16s, 
eBioscience) was added to the staining solution containing anti-BrdU mAb and labelling was 
performed as described.  
 
2.2.3.4 Enumeration of lymphocyte numbers by flow cytometry 
In experiments with large sample numbers a flow cytometric-based method with Fluosbrite 
microspheres (20 µm, Polyscience) as counting beads was used in order to quantify lymphocyte 
numbers. The concentration of the Fluosbrite microspheres stock solution was determined by counting 
in a haemocytometer and defined amounts were then added to the lymphocyte samples. Single cell 
suspensions from various lymphoid organs were prepared as described in 2.2.1. After washing cell 
pellets were resuspended in a defined volume (200 µl – 2 ml) of PBS/BSA. In the following a defined 
aliquot was removed for enumeration and mixed with an equal volume of Fluosbrite microspheres. 
Shortly before flow cytometric analysis of these mixtures fluorochrome-labelled CD4 mAb was 
added. Without washing the mixed suspension was measured and at least 3000 fluorescent beads were 
acquired. Due to their high SCC properties Fluosbrite microspheres do not interfere with lymphocyte 
scatter signals. This allows direct correlation of the event number in a lymphocyte region and the 
event number in the Fluosbrite bead region (Figure 3). The cell number was calculated according to 
the events in a lymphocyte and/or CD4 gate relative to the known number of fluorescent beads using 
the following equation: 
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clymph = nlymph / nFluosbrite x cFluosbrite 
 
cFluosbrite  = concentration of Fluosbrite microspheres determined by counting in haemocytometer 
clymph  = concentration of lymphocytes calculated using Fluosbrite microspheres 
nFluosbrite = event count of Fluosbrite microspheres determined by flow cytometry 
nlymph  = event count of lymphocytes determined by flow cytometry 
 
 
Figure 3: Enumeration of lymphocytes by flow cytometry using fluorescent beads  
The first dot plot shows all acquired events. A region was drawn on lymphocytes according to known FSC and 
SSC properties. The second dot plot shows CD4 staining of all lymphocytes gated as shown in the first dot plot. A 
region was drawn on CD4+ lymphocytes. The third dot plot depicts the Fluosbrite microspheres detected in channel 
FL1, a region was drawn in order to calculate the event number. Numbers in all dot plots indicate the event number 
in the respective gates. Due to the differential SSC properties, lymphocytes and Fluosbrite microspheres (beads) 
cannot be properly displayed in the same dot plot.   
 
 
2.2.3.5 Labelling of T cells with CFSE 
In order to follow proliferation of T cells both in vivo and in vitro freshly isolated T cells were labelled 
with the amin-reactive cell tracker dye 5-carboxy-fluorescein diacetate succinimidyl ester (CFSE). 
This compound is taken up by cells and cleaved by endogenous cytoplasmic esterases, which enables 
covalent binding of the succinimidyl-group of the dye to amin-residues of intracellular proteins. 
During cell division the CFSE-labelled proteins are evenly distributed between the two daughter cells 
leading to a reduction of fluorescence intensity of individual cells by a factor of two. This loss of 
fluorescence intensity can be analysed by flow cytometry and allows identification of single 
generations of proliferating cells.  
For labelling, T cells were washed twice in PBS and adjusted to 2 x 107 cells/ml in PBS. An equal 
volume of CFSE solution (5 nM in PBS) was added to the cell suspension and incubated for 3 min at 
RT. Washing with at least 10-fold excess volume of complete medium or PBS/BSA terminated the 
reaction. Labelled cells were subsequently activated in vitro by various procedures or adoptively 
transferred and activated in vivo. Analysis of proliferation was done by flow cytometry of cultured 
cells or re-isolated ex vivo cells 3-7 days after labelling. Loss of CFSE intensity was expressed as 
geometric mean fluorescence intensity (GMFI).    
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2.2.4 In vitro culture and activation of T cells 
T cells were cultured in complete medium in a humidified CO2- Incubator at 37° C. 
 
2.2.4.1 Generation of Th1 cells 
Th1 cells were generated by antigen-specific activation of naïve CD4+CD62Lhigh T cells (2.2.2.1) from 
DO11.10 mice. This mouse strain contains T cells with transgenic (tg) TCRs specific for the chicken 
ovalbumin323-339 (OVA323-33) peptide (Murphy, et al., 1990). Naïve DO11.10 T cells were activated 
under Th1 polarising conditions by co-culture with peptide-loaded antigen presenting cells (APCs). As 
APCs CD90- lymphocytes were prepared from spleen and LNs using anti-CD90 MicroBeads and 
autoMACS separation and were subsequently irradiated (γ-irradiation, 30 Gy). Sorted T cells were 
adjusted to 2 x 106 cells/ml in complete medium and activated at a ratio of 1 to 3 with CD90- APCs, 
together with 1 µg/ml OVA323-339 peptide, anti-IL-4 (5 µg/ml), IFN-γ (20 ng/ml) and IL-12 (5 ng/ml). 
The cultures were diluted by a factor of 1 to 3 in fresh medium on day 3 and transferred to new plates. 
On day 6 of the culture, cells were harvested and dead cells removed by carefully layering the cell 
suspension on Nycodenz solution (17.1% isotonic Nycodenz, Nyegaard) and subsequent density-
gradient centrifugation at 780 x g for 10 min at RT. Live cells were collected from the interface and 
washed twice with PBS/BSA. Th1 cells were used for the induction of a DTH reaction (2.2.5.4).  
 
2.2.4.2 In vitro proliferation assay 
In order to assess the functional activity of Tregs, co-culture assays with naïve CFSE-labelled 
CD4+CD25- responder cells were performed. Suppressive capacity of the Treg fraction was measured 
indirectly by following the proliferation of the responder cells using flow cytometry. 
Naïve CD4+CD25-CD62Lhigh responder T cells were isolated and labelled with CFSE as described 
above (2.2.2.1 and 2.2.3.5). APCs were prepared by depletion of CD90+ cells from CD4- fractions 
using anti-CD90 MicroBeads and were irradiated (30 Gy) prior to culture. Unlabelled Tregs were 
mixed with CFSE-labelled responder cells at different ratios (1:2 – 1:50). A total of 8 – 10 x 104 T 
cells were cultured with APC at a 1:2 ratio in 96-well U-bottom plates with addition of anti-CD3 mAb 
(1 µg/ml) for 3 days in triplicates. After incubation, cells were collected and analysed by FACS. To 
exclude dead cells, PI was added immediately before acquisition. Proliferation analysis is based on the 
CFSE GMFI of total CFSE+ T cells. 
 
2.2.4.3 Induction of homing receptors on Tregs by tissue-specific DCs  
For induction of organ-specific homing receptor expression naïve CD4+CD25+ Tregs were antigen-
specifically activated in vitro in the presence of tissue-specific DCs. 2 x 105 isolated Tregs (2.2.2.3) 
from DO11.10 mice were cultured for 4 days in 96-well U-bottom plates together with 2 x 104 CD11c+ 
DCs (2.2.2.4) in the presence of 1 µg/ml OVA323-339 peptide and 40 ng/ml recombinant IL-2 (R&D 
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Systems) in complete medium. Fresh medium containing IL-2 was added to the cultures on day 3 and 
proliferating cells were diluted by a factor of 1 to 2. After incubation, cells were collected and 
analysed for homing receptor expression by FACS.  
 
2.2.4.4 Induction of homing receptors on Tregs by soluble factors 
Naïve CD4+CD25+ Tregs were isolated as described above (2.2.2.3) and stimulated on anti-CD3 (6 
µg/ml) and anti-CD28 (4 µg/ml) coated plates together with IL-2 (40 ng/ml). Cultures were performed 
either under neutral (anti-IL-12, 5 µg/ml) or under polarising conditions with RA (100 nM), anti-IL-12 
(5 µg/ml) and IL-12 (5 ng/ml), respectively. On day 3 of the culture, Tregs were removed from the 
mAb-coated plates, transferred to fresh wells and rested for another 2-3 days before analysis of 
homing receptor expression by FACS. In some experiments naïve CD4+CD25- CD62Lhigh T cells were 
stimulated under neutral or polarising conditions as described above, except that no exogenous IL-2 
was added. Cell culture and analysis were performed as described above. 
 
2.2.5 In vivo experiments and adoptive transfer 
Mice were kept under specific-pathogen free (SPF) conditions, unless otherwise stated. Killing was 
carried out by cervical dislocation under authorisation of Genehmigungs-Nr. T0085/99 and 
experiments with live animals were performed according to Tierversuchsgenehmigung G0202/03.  
 
2.2.5.1 In vivo labelling with BrdU  
In order to follow proliferation of Tregs in vivo, BrdU (Sigma Aldrich) was added to the drinking 
water of mice at 1 mg/ml and changed every 2-3 days. The thymidin analog incorporates during cell 
division into newly synthesised DNA. This allows specific labelling of cells that have proliferated 
during the period of BrdU administration (Gratzner and Leif, 1981; Miltenburger, et al., 1987; Sasaki, 
et al., 1989). After 10 days of BrdU feeding, mice were sacrificed and cell suspensions were prepared 
from different lymphoid organs. Cell surface staining was performed as described in 2.2.3.1. 
Incorporation of BrdU was detected by using the BrdU Flow Kit (BD Bioscience) according the 
procedure described above (2.2.3.3).  
To discriminate thymic from peripheral proliferation, thymectomised animals were used in initial 
experiments. In later experiments discrimination of thymic and peripheral proliferation was based on 
differential BrdU staining intensity. According to an observation reported by Sprent and Tough only 
peripheral proliferation of T cells led to high BrdU and high CD44 staining intensities, while T cells 
that had proliferated in the thymus showed lower BrdU and CD44 staining intensities. Consequently, 
this population was found missing in mice that had been thymectomised prior to BrdU administration 
((Sprent and Tough, 1994) and Figure 4). Furthermore, evaluation of thymic tissue for BrdU 
incorporation confirmed that the specific microenvironment of the thymus resulted in low BrdU 
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staining intensities (data not shown). Based on these findings, the frequency of BrdUhigh cells was 
taken as a measure for peripheral proliferation of the T cells subsets of interest.  
 
 
Figure 4: Evaluation of peripheral proliferation by differential BrdU staining intensity 
Differential staining properties of T cells following in vivo labelling with BrdU and detection of incorporated BrdU 
by intracellular staining with anti-BrdU mAb were confirmed in an initial test experiment. Control C57BL/6 mice 
or thymectomised C57BL/6 mice were given BrdU in the drinking water for a period of 10 days. Staining for 
surface molecules (CD4, CD44) and incorporated BrdU was performed as described in 2.2.3.1 and 2.2.3.3. 
Lymphocytes obtained from a mouse that had not received BrdU (unfed) were subjected to the same staining 
protocol and used for determination of BrdU staining specificity. Dot plots show staining of CD44 vs. BrdU of 
CD4-gated LN cells from non-thymectomised mice (unfed and control) and a thymectomised mouse.  
 
 
2.2.5.2 Depletion of commensal microflora 
In some experiments commensal microflora of C57BL/6 mice was depleted. Treatment was done in 
collaboration with M.M. Heimesaat and O. Liesenfeld (Charité, Berlin) according to a standard 
protocol with minor modifications (Rakoff-Nahoum, et al., 2004). Groups of mice were given a 
cocktail of antibiotics (ampicillin, 1 g/L, Ratiopharm; vancomycin, 500 mg/L, Cell Pharm; 
ciprofloxacin, 200 mg/L, Bayer Vital; imipenem, 250 mg/L, MSD; metronidazole, 1 g/L, Fresenius) 
added to the drinking water ad libitum for 8 weeks. Mice were housed in sterile cages, which were 
changed daily for the first two weeks. Efficient bacterial eradication was monitored by weekly 
bacteriologic evaluation of faeces from individual mice. Lack of cultivable bacteria (Gram-negative 
rods, Gram-positive rods, Gram-positive cocci, aerobic and anaerobic cultures) for at least two 
consecutive weeks was taken as indication of complete removal of commensal microflora as described 
by Heimesaat et al. (Heimesaat, et al., 2006). These gnotobiotic mice were used for in vivo labelling 
with BrdU as described above (2.2.5.1). 
 
2.2.5.3 Antigen-specific activation in vivo 
In order to follow the induction of Foxp3 and αE expression upon antigen-specific activation in vivo, a 
model of adoptive transfer was applied. αE- cells from DO11.10 mice were isolated, labelled with 
CFSE and transferred into BALB/c recipient mice. Transferred cells were activated by administration 
of OVA protein and analysed 5 - 7 days later by flow cytometry. This allowed analysis of phenotypic 
changes on the single cell level in correlation to proliferation.  
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Cells were sorted and labelled with CFSE as described above (2.2.2.2 and 2.2.3.5). 4 – 6 x 106 
αE
-CD25-CD62Lhigh or 6 – 9 x 105 αE-CD25+ cells were injected in a volume of 200 µl PBS i.v. into 
the tail vein of BALB/c mice. On the next day, OVA protein (Sigma Aldrich) was administered for 
antigen-specific activation in vivo. The tolerogenic protocol involved continuous feeding of OVA 
protein at various doses (0.5 – 20 mg/ml) in the drinking water for 6 days and preparation of lymphoid 
organs on day 7. For immunogenic antigen administration recipient mice were injected once with 
200 µl PBS containing 500 µg of OVA protein and 70 µg LPS (Sigma Aldrich) i.p. and mice were 
sacrificed on day 5. Cell surface staining was performed on single cell suspensions from different 
lymphoid organs, followed by fixation, permeabilisation and intracellular staining for Foxp3 as 
described above (2.2.3.2). Cells were analysed by flow cytometry and transferred tg cells were 
identified by gating on CD4+ and KJ1.26+ cells.  
 
2.2.5.4 Th1-mediated DTH model 
This model of an acute skin inflammation is based on the adoptive transfer of antigen-specific Th1 
cells into recipient mice. One day after transfer, the DTH reaction in the footpad is triggered by s.c. 
injection of the cognate antigen. This leads to an acute local inflammation, which can be followed by 
measuring the swelling of the foot over time. The peak of the swelling/inflammation occurs 24 h after 
antigen application and slowly declines over a period of 2 weeks (Feuerer, et al., 2006; Siegmund, et 
al., 2005).  
Th1 cells were generated from OVA-specific TCR-tg CD4+ T cells as described above (2.2.4.1). 5 x 
105 Th1 cells were injected i.v. into naïve BALB/c mice, and 24 h later the DTH response was induced 
by s.c. injection of 250 ng OVA323-339 peptide together with incomplete Freud’s Adjuvant (IFA, Sigma 
Aldrich) into the left footpad. As a control the right footpad was injected with PBS/IFA. The course of 
the swelling was followed over 2 weeks by measuring the thickness of the footpad daily using a 
calliper. Measurements were performed in blinded fashion. This model was used for evaluation of 
skin-specific migration (2.2.5.5) and in vivo suppressive capacity of cultured Tregs. For analysis of 
Treg function, Tregs cultured under various conditions (2.2.4.4) were co-transferred together with Th1 
cells at a ratio of 1:2. For analysis of Treg migration DTH mice were used on day 1 after s.c. antigen 
application.  
 
2.2.5.5 Homing of adoptively transferred Tregs 
In order to analyse the migratory behaviour of Tregs in vivo, they were radioactively labelled and 
adoptively transferred into recipient mice. After 24 h mice were sacrificed and the distribution of 
transferred Tregs was analysed by detection of radioactivity in various organs. In order to generate a 
specific target site for migration into inflamed skin, recipient mice suffering from an acute skin-
inflammation were used (Th1-mediated DTH model). Recipient mice had received Th1 cells and 
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antigen as described in 2.2.5.4 and were used for homing assays on day 1, at the peak of inflammation.  
Tregs cultured as described above (2.2.4.4) were labelled with 111In (111Indiumoxin; 10 µCi/ml) 
(Amersham Biosciences) at a cell density of 0.5 - 1x108 cells/ml in FCS-free medium for 20 min at 
RT. Labelling was terminated by washing twice with complete medium, followed by 1 h incubation at 
37°C in fresh medium and removal of dead cells by Nycodenz gradient centrifugation. Labelled cells 
were injected i.v. into BALB/c mice, which suffered from a DTH reaction in the footpad. In all 
experiments a minimum of 104 cpm was injected. Mice were sacrificed 24 h after transfer of labelled 
cells and the distribution of radioactivity in different organs, serum and the remaining body was 
measured in a γ-counter (Wallac Counter). Homing assays were performed in cooperation with Uta 
Lauer, Kerstin Siegmund and Astrid Menning (Exp. Rheumatology, Charité, Berlin). 
 
2.2.5.6 Data management and statistical analysis 
The results obtained in this study were either represented as single values or as mean ± standard 
deviation (SD). Since normal distribution could not be assumed for the collected data, for statistical 
analyses non-parametric tests were used to determine significant differences. For paired observations 
the Wilcoxon signed rank test and for unpaired observations the Mann Whitney test were used, 
respectively. In order to allow analysis of data, where the sample size was lower than the minimally 
required number of observations for non-parametric tests, the Student’s t test was used instead. 
Differences were considered statistically significant, when p < 0.05 and highly significant when 
p < 0.01. Statistical analysis was done using GraphPad Prism and SPSS software. Help with statistical 
analyses was kindly provided by D. Hüscher (DRFZ, Berlin).  
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3 Results 
3.1 Origin and development of Tregs 
This part of the project was initiated in order to analyse the relationship between various subsets of 
CD4+ Tregs. Of particular interest were Treg subpopulations characterised by the expression of the 
integrin αEβ7. Here, conditions leading to the generation of effector/memory αE+ Tregs in vivo were 
defined and their cellular precursors as well as the sites, at which generation and expansion take place, 
were investigated. 
 
3.1.1 Phenotype and in vivo proliferation of effector/memory-like Tregs 
3.1.1.1 αE-expression on CD4+Foxp3+ Tregs correlates with an effector/memory phenotype 
Previous results from our group identified a close link between expression of αE on naturally occurring 
Tregs and expression of adhesion molecules and activation markers associated with an 
effector/memory phenotype. At the same time RT-PCR results demonstrated similar levels of Foxp3 
mRNA among αE/CD25 Treg subsets, however a direct correlation on the single cell level was not 
demonstrated (Huehn, et al., 2004). Therefore, in the study presented here, the marker profile of 
CD4+Foxp3+ Tregs from the spleen of C57BL/6 mice was analysed in order to assess the phenotype of 
αE
+ and αE- Treg subsets. αE-CD25+ cells contained 78.4 ± 7.7%, αE+CD25+ cells 88.2 ± 6.3% and 
αE
+CD25- cells 58 ± 9.6% Foxp3+ cells, respectively (mean ± SD, n=17). Investigation of the co-
expression of Foxp3 and CD62L or CD44 confirmed, that αE-expression on CD4+Foxp3+ Treg subsets 
was tightly linked to an effector/memory-like phenotype. The majority of αE-CD25+Foxp3+ Tregs was 
positive for CD62L and expressed only low levels of CD44, which corresponded to their previously 
described naive-like phenotype. In contrast, both αE+Foxp3+ Treg subsets expressed much higher 
levels of CD44 and lower amounts of CD62L, indicating a higher activation/differentiation state. 
These results confirmed the initial observation that αE-expression correlates with an effector/memory-
like phenotype on the single cell level for CD4+Foxp3+ Tregs.  
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Figure 5: Effector/memory phenotype of CD4+Foxp3+ cells segregates with expression of αE 
Lymphocytes were isolated from peripheral lymphoid organs of mice and stained with fluorochrome-labelled 
antibodies to CD4, CD25, CD62L, CD44 and αE. Cells were subsequently fixed and permeabilised for intracellular 
staining of Foxp3 followed by flow cytometric analysis. (a) The left dot plot shows FCS vs. SSC of all acquired 
events. A region (R1) was drawn on lymphocytes according to their known scatter properties excluding debris and 
doublets from further analysis. The middle dot plot represents CD4 staining of cells gated according to the 
lymphocyte region R1. A new region (R2) was drawn on all CD4+ lymphocytes. The right dot plot shows staining 
of CD25 vs. αE of gated CD4+ lymphocytes (combined lymphocyte (R1) and CD4+ (R2) gate). The quadrant 
subdivides the gated CD4+ lymphocytes according to expression of the respective markers. (b) Flow cytometric 
analysis of spleen cells from C57BL/6 mice for the expression of Foxp3 and CD62L or CD44 on indicated CD4+ 
Treg subsets. CD4+ lymphocytes were gated according to expression of αE and CD25 as shown in (a) and analysed 
for indicated markers. Numbers show frequency within respective quadrants. Dot plots are representative of at least 
two independent experiments with 2-3 individual mice each.  
 
 
3.1.1.2 αE+ Tregs show high proliferation under homeostatic conditions 
Based on the previous observation that αE+ Tregs harbour reduced T cell receptor excision circle 
(TREC) numbers, indicative of increased proliferative history (Huehn, et al., 2004), the following 
experiments addressed the question whether this is the consequence of peripheral proliferation. To 
exclude any impact of thymic proliferation, adult-thymectomised mice were used for the evaluation of 
peripheral proliferation by BrdU incorporation. Four weeks after thymectomy C57BL/6 mice were 
given BrdU in their drinking water for a period of 10 days. Mice were sacrificed on day 10 of BrdU-
feeding and spleen and LNs were evaluated for BrdU+ cells. Incorporation of BrdU was analysed by 
flow cytometry. Single cell suspensions from various lymphoid organs were stained for the expression 
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of surface molecules, followed by fixation and permeabilisation as described in 2.2.2. BrdU was 
detected using a specific mAb. 
Figure 6 shows representative staining of incorporated BrdU among gated CD4+ αE/CD25 subsets 
from pLN cells. High frequencies of BrdU+ cells were detected in all three Treg subsets, while the 
predominantly naïve fraction of αE-CD25-CD4+ T cells showed only low frequencies of BrdU+ cells 
(Figure 6a). Within the Treg subsets αE+CD25- cells showed the highest frequency of BrdU-labelled 
cells in all of the tested lymphoid organs (Figure 6), indicating that a substantial number of cells had 
proliferated within the 10 days of BrdU administration. αE+CD25+ cells showed only slightly reduced 
frequencies of BrdU+ cells compared to αE+CD25- cells and the lowest frequency was detected among 
the αE-CD25+ Tregs.  
These data correspond to the phenotype of the respective Treg subsets (Figure 5) and to the previous 
observation that αE+ Treg subsets have reduced TREC numbers, suggesting, that indeed these cells 
display a high degree of peripheral proliferation under steady state conditions. 
 
 
Figure 6: Evaluation of in vivo proliferation by incorporation of BrdU 
Adult-thymectomised C57BL/6 mice were given BrdU in the drinking water for a period of 10 days. Single cell 
suspensions were prepared from lymphoid organs and stained for expression of CD4, CD25 and αE. Incorporation 
of BrdU was detected by intracellular staining with anti-BrdU and subsequent flow cytometric analysis. Cells were 
gated according to the expression of CD4 and αE/CD25 subsets as shown in Figure 5 and analysed for the 
frequency of BrdU+ cells. (a) Control staining for BrdU of gated CD4+ T cells isolated from pLN of a control 
mouse, which did not receive BrdU in the drinking water (unfed control). Representative staining for BrdU of 
gated CD4+ αE/CD25 subsets from pLN of mice after 10 days of continuous BrdU feeding (right pannel). (b) Data 
summarise the frequency of BrdU+ cells among Treg subsets for the indicated lymphoid tissues. Data are pooled 
from two independent experiments and single data points represent individual mice, lines indicate the median. * p 
< 0.05; ** p < 0.01. 
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3.1.1.3 αE+ Treg numbers are stable in the absence of thymic output 
During analysis of the relative distribution of αE/CD25 Treg subsets highly increased frequencies of 
αE-expressing Tregs in thymectomised mice compared to non-thymectomised control mice were 
observed (Figure 7a). In addition, calculation of the total cell number according to the method 
described in 2.2.3.4. revealed that the number of total CD4+ T cells was reduced in thymectomised 
animals (Figure 7b), presumably due to the lack of thymic output of newly generated T cells. In 
contrast, the total number of αE-expressing Tregs in thymectomised mice was found to be similar to 
control mice (Figure 7b). This indicated that the high frequency was rather the result of a selective 
decrease of all other T cells leading to a skewed ratio between conventional CD4+ T cells and αE+ 
Tregs. This shift only affected the effector/memory-like αE+ Tregs but not the naïve-like αE-CD25+ 
Tregs.  
 
Figure 7: αE+ Treg numbers are unaffected by thymectomy 
Adult-thymectomised C57BL/6 mice were analysed for the frequency and cell number of CD4+ T cell subsets and 
compared to non-thymectomised age-matched control mice. Enumeration of lymphocyte numbers was done using 
a flow cytometric based assay (2.2.3.4) in combination with flow cytometric analysis of lymphocyte subsets 
stained for CD4, αE and CD25. (a) Frequency of CD4+ αE/CD25 Treg subsets in indicated organs from control 
(open symbols) and thymectomised mice (filled symbols). (b) Absolute cell numbers of CD4+ T cells (left) and 
CD4+ αE/CD25 Treg subsets (right) in indicated organs. Data are pooled from two independent experiments and 
single data points represent individual mice, lines indicate the median. * p < 0.05; ** p < 0.01. 
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3.1.1.4 Removal of intestinal microflora affects in vivo proliferation of CD4+Foxp3+ Tregs 
The gut associated lymphoid tissue (GALT) favours tolerogenic immune reactions against dietary and 
commensal-flora derived antigen (Dubois, et al., 2005). The strong mitotic activity among αE+ Tregs 
from mLN suggested that proliferation of Tregs might be, at least in part, driven by environmental 
antigen acquired from the intestinal lumen. In order to investigate whether the observed proliferative 
activity of Tregs was somehow related to microbial stimuli derived from the intestine, comparable 
experiments were performed using gnotobiotic mice. These mice had been generated by treating adult 
specific-pathogen free (SPF) mice with a cocktail of antibiotics for a period of 8 – 10 weeks as 
described in 2.2.5.2. Upon successful eradication of the gut flora as judged by regular bacteriological 
investigation of faeces samples, BrdU was administered in the drinking water of antibiotics-treated 
and untreated control mice, respectively. After 10 days of continuous feeding, mice were sacrificed 
and CD4+ Tregs from various lymphoid organs were analysed for incorporation of BrdU. In the 
following set of experiments intracellular staining for Foxp3 was included, allowing a more accurate 
evaluation of cycling Foxp3+ Treg subsets. Furthermore, non-thymectomised animals were used and 
therefore only the frequency of BrdUhigh cells was taken as a measure for peripheral proliferation as 
described in 2.2.5.1. Figure 8 shows representative co-staining for BrdU and Foxp3 of gated CD4+ 
αE/CD25 subsets from mLN of untreated control mice. This revealed that there is also a considerable 
BrdUhigh population among αE-CD25-Foxp3+ Tregs. This subset was previously unrecognised, as no 
specific surface marker is known to identify it. The αE-CD25- Treg subset showed similar frequencies 
of BrdUhigh cells as the αE+CD25- Treg subset in PP, mLN and spleen (Figure 8b). When comparing 
peripheral proliferation in control mice vs. antibiotics-treated mice, all Foxp3+ αE/CD25 subsets 
showed a significant reduction in the frequency of BrdUhigh cells in PPs, while only the αE+CD25+ 
Tregs displayed significantly reduced BrdUhigh frequency in mLN. No difference was observed 
between control and treated mice in the spleen. Surprisingly, in pLN, the frequency of BrdUhigh cells 
was even increased among αE+CD25- Tregs from antibiotics-treated mice.  
Evaluation of absolute numbers of BrdUhigh cells among Foxp3+ αE/CD25 Treg subsets revealed 
reduced numbers of cycling BrdUhigh Tregs in all organs analysed upon treatment with antibiotics. This 
numerical decrease of proliferating Tregs was significant in all Treg subsets, except the αE-CD25+ 
Tregs, where the reduction did not reach statistical significance.  
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Figure 8: Microbial stimuli influence peripheral proliferation of Treg subsets 
C57BL/6 mice were treated with a cocktail of antibiotics ad libitum for a period of 8-10 weeks. Upon successful 
eradication of the intestinal microflora BrdU was administered for 10 days followed by flow cytometric analysis of 
CD4, CD25, αE and Foxp3 expression and BrdU incorporation. (a) Dot plots show representative intracellular 
staining of gated CD4+ T cell subsets from mLN of control mice for Foxp3 and BrdU. Numbers indicate the 
frequencies of BrdUhigh cells among Foxp3+ subsets (upper two quadrants). (b) Data summarise the frequencies of 
BrdUhigh cells among Foxp3+ αE/CD25 subsets from indicated lymphoid tissues of untreated control (open 
symbols) and antibiotics-treated mice (filled symbols), respectively. (c) Absolute cell number of BrdUhigh cells 
among Foxp3+ αE/CD25 subsets from indicated organs of untreated control (open symbols) and antibiotics-treated 
mice (filled symbols), respectively. Data are pooled from two independent experiments and single data points 
represent individual mice, lines indicate the median. * p < 0.05; ** p < 0.01. 
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3.1.1.5 Lack of microbial stimuli results in reduced cell numbers of Foxp3+ Tregs 
The overall frequency of CD4+ T cells in antibiotics-treated mice was unchanged compared to 
untreated control mice, however, the total number of lymphocytes was decreased (Figure 9). As a 
consequence the absolute CD4+ T cell number was reduced upon depletion of commensal microflora 
in all organs analysed. The CD4+ T cell number of control mice vs. antibiotics-treated mice in spleen 
was 8.0 ± 3.7 x 106 vs. 5.3 ± 1.6 x 106; in pLN 4.0  ± 0.4 x 106 vs. 3.2 ± 0.9x 106; in mLN 3.3 ± 1.0 x 
106 vs. 2.6 ± 0.4 x 106 and in PP 3.2 ± 1.9 x 105 vs. 1.6 ± 0.9 x 105 (mean ± SD, n=10). The frequency 
of Foxp3+ Tregs in antibiotics-treated mice was similar to control mice, only in mLN a significant 
lower frequency was observed (Figure 9d). Consequently, the absolute cell numbers of Foxp3-
expressing CD4+ T cells were decreased similar to the overall lymphocyte numbers upon eradication 
of the microflora (data not shown).  
 
 
Figure 9: Reduced lymphocyte numbers upon removal of intestinal bacteria 
C57BL/6 mice were treated with a cocktail of antibiotics ad libitum for a period of 8-10 weeks. Upon successful 
eradication of the intestinal microflora mice were analysed for the frequency and cell number of CD4+ T cell 
subsets and compared to untreated control mice. Enumeration of lymphocyte numbers was done using a flow 
cytometric based assay (2.2.3.4) in combination with flow cytometric analysis of lymphocyte subsets stained for 
CD4 and Foxp3. (a) Absolute cell number of lymphocytes isolated from indicated organs of untreated control 
(open symbols) and antibiotics-treated mice (filled symbols), respectively. (b) Dot plot shows representative 
staining of lymphocytes from mLN of control mice for CD4 and Foxp3. (c) Frequency of CD4+ T cells among 
lymphocytes and (d) Foxp3+ cells within CD4+ T cells from indicated organs. Data are pooled from two 
independent experiments and single data points represent individual mice, lines indicate the median. * p < 0.05; ** 
p < 0.01. 
 
Interestingly, when the ratio of αE/CD25 subsets among Foxp3+ Tregs was compared in the two 
experimental groups, the frequency of naïve-like αE-CD25+ Tregs was significantly increased upon 
removal of bacterial stimuli. The frequencies of the other αE/CD25 Treg subsets were either 
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unchanged or even decreased under these conditions (Figure 10b and Appendix 1). Despite the overall 
reduction in lymphocyte numbers the reduction in αE-CD25+ Tregs did not reach statistical 
significance (p = 0.1331 in mLN; p = 0.6607 in PP; p = 0.0753 in spleen and p = 0.4002 in pLN), in 
contrast to the remaining αE/CD25 Foxp3+ Tregs (Figure 10c). 
 
 
Figure 10: Microbial stimuli influence cell numbers of Foxp3+ αE/CD25 Treg subsets 
C57BL/6 mice were treated with a cocktail of antibiotics ad libitum for a period of 8-10 weeks. Upon successful 
eradication of the intestinal microflora mice were analysed for the frequency and cell number of CD4+ T cell 
subsets and compared to untreated control mice. Enumeration of lymphocyte numbers was done as described in 
Figure 9 and Foxp3-gated cells were analysed for the frequency and cell number of αE/CD25 Tregs. (a) 
Representative dot plots showing staining of CD4 vs. Foxp3 on lymphocytes isolated from mLN of control mice 
(left) and staining of αE vs. CD25 on CD4+Foxp3+ gated cells (right). (b) and (c) The results obtained in two 
independent experiments were pooled and used to calculate the median frequency and the median cell number of 
each Treg subset. The values obtained from untreated control animals were defined as 100 % and the relative 
change in antibiotics-treated mice was calculated and expressed as % of control. (b) Relative change in the 
frequency of αE/CD25 Treg subsets among CD4+Foxp3+ cells in indicated organs from antibiotics-treated mice (% 
of control). (c) Relative change in cell numbers of CD4+Foxp3+ αE/CD25 Tregs in indicated organs. Graphs 
include data from two independent experiments (n=10); dashed lines indicate 100 % of the untreated control group. 
Statistical analysis was performed on raw data and transferred to this graph. Single data points of frequency and 
cell number are displayed in Appendix 1. * p < 0.05; ** p < 0.01. 
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Taken together, these data from gnotobiotic mice suggest that local proliferation of CD4+Foxp3+ Treg 
subsets in GALT is substantially driven by microbial stimuli. Removal of these stimuli not only led to 
reduced proliferation but also decreased the total numbers of Tregs in GALT, spleen and pLN. Only 
naïve-like αE-CD25+ Tregs were less affected, primarily in their relative frequency but also in their 
overall cell number. These findings support the view that naïve-like αE-CD25+ Tregs are less 
dependent on environmental factors for their peripheral homeostasis than effector/memory-like αE+ 
and αE-CD25- Foxp3+ Treg subsets. In contrast, it suggests that differentiation into an 
effector/memory-like phenotype might be diminished under these conditions leading to a relative 
increase of this subset.  
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3.1.2 Generation of effector/memory-like Foxp3+ Tregs by antigen-specific activation  
in vivo 
The previous experiments confirmed that the effector/memory-like phenotype of αE-expressing Tregs 
indeed correlated with a high degree of peripheral/homeostatic proliferation in normal, healthy mice. 
However, these data did not clarify whether expansion of preformed natural Tregs or de novo 
induction of Tregs from naïve T cells occurred under the investigated conditions. Given that naturally 
occurring Tregs are thought to originate from the thymus, where they are positively selected to 
recognition of self-antigen, acquisition of the effector/memory phenotype could be a consequence of 
activation by self-antigen in the periphery, i.e. in secondary lymphoid tissue draining the site of 
respective self-antigen expression (Walker, et al., 2003). In this case naïve-like αE- Tregs should 
differentiate into effector/memory-like αE+ Tregs upon antigen-specific stimulation in vivo. In order to 
address this question the experimental set up was switched from analysis of the polyclonal T cell pool 
to an antigen-specific system, where it was possible to follow the immune response to known cognate 
antigen.  
 
3.1.2.1 In vivo conversion of naïve-like CD25+ Tregs into αE+ Tregs  
CD25+ Tregs from OVA specific TCR-tg DO11.10 mice were used to analyse antigen-specific 
activation upon adoptive transfer. It has to be noted that CD25+ Tregs in TCR-tg mice preferentially 
express second endogenous TCRs required for their selection in the thymus (Itoh, et al., 1999). This 
occurs at the expense of the tg TCR (Hurst, et al., 1997) and therefore the fraction of T cells 
expressing endogenous TCRs is higher among CD25+ Tregs as compared to CD25- T cells (~60 % vs. 
~30 % in DO11.10 mice). However, in the DO11.10 mouse model tg TCRs can be idendified with the 
clonotypic anti-OVA TCR mAb KJ1.26 and thus, flow cytometric analysis of antigen-specific T cell-
responses is possible.  
Naïve-like αE-CD25+ Tregs were isolated from DO11.10 mice (2.2.2.2). After adoptive transfer of 
CFSE-labelled DO11.10 Tregs into naive BALB/c recipients the cognate antigen was administered ad 
libitum in the drinking water, a route that is known to result in tolerance induction (Mayer and Shao, 
2004). Proliferation and phenotype of transferred cells were followed by multicolour flow cytometry. 
Transferred cells were identified among endogenous CD4+ T cells based on staining with the 
clonotypic mAb KJ1.26 and CFSE. Continuous feeding of recipient mice with different doses of OVA 
protein (4 to 20 mg/ml) in the drinking water for a period of 6 days led to moderate proliferation of the 
antigen-specific KJ1.26+CD25+ Tregs in gut-associated lymphoid organs such as the celiac LN 
draining liver, pancreas and stomach (livLN) (Matsuno, et al., 1990) and mLN. Hardly any tg CD25+ 
Tregs were detected in PP and spleen (data not shown). When transferred CD25+ cells were analysed 
for their phenotype, a high degree of co-expression of αE on previously αE-CD25+ cells was detected 
upon antigen-driven proliferation (Figure 11b). The frequency of αE on CD25+ cells increased with 
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each division as judged by loss of CFSE and reached similar levels both in livLN and mLN (Figure 
11c). Importantly, transferred CD25+ Tregs maintained expression of CD25 and Foxp3 upon in vivo 
activation and proliferation (Figure 12). Together, these results support the concept that upon antigen-
specific activation in the periphery naïve-like αE-CD25+ Tregs differentiate into effector/memory-like 
Tregs characterised by expression of αE.  
 
 
Figure 11: αE is induced on naïve-like CD4+CD25+ Tregs upon antigen-specific activation 
Pooled spleen and LN cells from DO11.10 mice were depleted of αE+ cells and enriched for naïve-like CD25+ T 
cells by MACS. Purified αE-CD25+ cells were labelled with CFSE, adoptively transferred into BALB/c recipients 
and subsequently stimulated in vivo by oral application of their cognate antigen. (a) Dot plots show staining of 
CD25 vs. αE and KJ1.26 vs. Foxp3 of CD4+CD25+ DO11.10 Tregs before transfer. (b) After 6 days of continuous 
feeding with OVA, mice were sacrificed and lymphocytes were analysed by flow cytometry. Transferred cells 
were identified according to CD4+KJ1.26+ staining and CFSE. Dot plots show representative analysis of αE-
expression and proliferation of re-isolated Tregs in livLNs and mLNs after feeding different doses of OVA. (c) 
Frequencies of αE+ Tregs in indicated lymphoid organs after different doses of OVA in drinking water. Data 
represent mean ± SD of 3 individual mice per group.  
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Figure 12: Naïve-like CD4+CD25+ Tregs remain CD25+ and Foxp3+ upon antigen-specific activation 
Purified αE-CD25+ Tregs were labelled with CFSE and adoptively transferred into BALB/c recipients. Recipient 
mice were continuously fed for 6 days with 10 mg/ml OVA in the drinking water and expression of Foxp3 and 
CD25 on transferred DO11.10 cells was analysed on day 7. Representative dot plots showing staining of CFSE vs. 
CD25 and Foxp3, respectively, on transferred CD4+KJ1.26+ T cells re-isolated from mLN after oral application of 
OVA. Numbers indicate the frequency of cells stained positive for the respective marker. Data are representative of 
at least two independent experiments with 2-3 mice each.  
 
 
3.1.2.2 In vivo generation of αE+Foxp3+ cells from conventional naïve T cells 
In order to investigate whether acquisition of the αE+ Treg phenotype could also occur by conversion 
of conventional naïve CD4+ T cells, corresponding experiments with adoptive transfer of naive 
αE
-CD25-CD62Lhigh T cells from DO11.10 mice and OVA administration via the oral route were 
performed. Proliferating tg KJ1.26+CD4+ T cells were detected in livLN, mLN, PPs and spleen at 
various doses of antigen (Figure 13b and Appendix 2). While slightly reduced proliferation in livLN 
was observed compared to the other organs (Appendix 2), a high proportion of tg Foxp3+ cells re-
isolated from the livLN was identified. The induction was dose-dependent and largely confined to this 
particular LN (Figure 13b and c), as the frequency of Foxp3+ cells was much lower in mLN and PP 
cells (Figure 13c). When the phenotype of these induced Foxp3+ cells was analysed, it was found that 
the vast majority of the cells co-expressed αE (Figure 14a) showing a proliferation-dependent up-
regulation of both markers on previously naïve, Foxp3- tg T cells in the livLN. Importantly, this 
induced Treg phenotype was only observed after tolerogenic antigen-administration. When recipient 
mice were immunised with OVA protein i.p. in the presence of the adjuvant LPS no significant up-
regulation/induction of αE or Foxp3 in the livLN were detected (Figure 14b), suggesting that induction 
of αE+Foxp3+ Tregs was restricted to antigen-specific activation under distinct tolerogenic conditions. 
At the same time it indicated that the specific microenvironment of the livLN is not a bona fide site for 
the induction of tolerance but, in contrast, is readily able to support proliferation of naive antigen-
specific T cells and their anticipated conversion into an effector Th phenotype in the presence of 
inflammatory stimuli.  
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Figure 13: De novo induction of Foxp3+ cells by antigen-specific activation in vivo 
Naïve T cells were isolated from DO11.10 mice by depleting αE+ and CD25+ cells and subsequent isolation of 
CD62Lhigh cells. Purified αE-CD25-CD62Lhigh cells were labelled with CFSE, adoptively transferred into BALB/c 
recipients and subsequently stimulated in vivo by oral application of their cognate antigen. (a) Dot plots show 
staining of CD62L vs. αE and Foxp3 vs. KJ1.26, respectively, of CD4+ DO11.10 T cells before transfer. (b) After 6 
days of continuous feeding with OVA, mice were sacrificed and lymphocytes were analysed by flow cytometry. 
Transferred cells were identified according to CD4+KJ1.26+ staining and CFSE. Dot plots show representative data 
of Foxp3-expression and proliferation of re-isolated DO11.10 T cells in indicated lymphoid organs after feeding of 
different doses of OVA. (c) Frequencies of Foxp3+ cells among transferred CD4+KJ1.26+ in indicated lymphoid 
organs after different doses of OVA in drinking water. Data represent mean ± SD from 3-4 individual mice per 
group.  
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Figure 14: αE as a marker of peripherally generated Foxp3+ Tregs 
Naïve αE-CD25-CD62Lhigh DO11.10 cells were isolated, CFSE-labelled and adoptively transferred as described in 
Figure 13. Recipient mice were continuously fed for 6 days with 10 mg/ml OVA in the drinking water and 
induction of Foxp3 and αE on transferred DO11.10 cells was analysed in livLN on day 7 (a). Alternatively, 
recipient mice were immunised by i.p. injection of 500 µg OVA with LPS one day after adoptive transfer of naïve 
αE
-CD25-CD62Lhigh DO11.10 cells and analysed for expression of Foxp3 and αE on transferred cells in livLN on 
day 5 (b). Representative dot plots showing staining of CFSE vs. Foxp3 or αE on transferred CD4+KJ1.26+ T cells 
in livLN after oral application of OVA (a) or i.p. immunisation with OVA/LPS (b). Regions indicate gating on 
individual generations according to CFSE-dilution. Graphs show frequency of αE+Foxp3+, αE+Foxp3- and αE-
Foxp3+ in individual generations of transferred transgenic T cells. Data represent mean ± SD of 6 individual mice 
from two independent experiments. Significance was calculated for the difference in frequency of αE+Foxp3+ vs. 
αE
-Foxp3+ in individual generations; * p < 0.05. 
 
 
An alternative explanation for the appearance of Foxp3+ Tregs after transfer of CD25- non-regulatory 
T cells could be selective outgrowth or survival of small numbers of contaminating Foxp3+ T cells 
transferred together with the inoculated cells. In order to address this issue the frequency and cell 
number of Foxp3+ Tregs among either CD25- or CD25+ precursor cells transferred separately into 
BALB/c recipient mice was analysed before and after antigen-specific activation in vivo. Table 3 
shows representative results indicating that a small number of Foxp3+ Tregs injected along with the 
CD25- T cells led to a similar yield of Foxp3+ Tregs in livLN and mLN as in the case of adoptive 
transfer of CD25+ containing almost 50 times more Foxp3+ cells in the initial inoculate. If selective 
outgrowth or survival was the cause for the emergence of Foxp3+ T cells among transferred CD25- 
cells, this would imply a 50-fold higher recovery of Foxp3+ cells compared to transfer and activation 
of naïve-like CD25+ under the same setting and in the same anatomical microenvironment. In addition, 
it was observed that Foxp3 was up-regulated even on the non-divided CFSEhigh fraction of transferred 
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CD25- cells, but only in the presence of cognate antigen, indicating that selective outgrowth of the pre-
existing 0.12% of Foxp3+ cells did not account for this population (Figure 14b). Collectively, these 
findings argue against emergence of Foxp3+ Tregs by expansion of pre-existing CD25-Foxp3+ Tregs 
and rather support the view that Foxp3+ Tregs were induced from conventional naïve CD25- T cells.  
 
Table 3: Foxp3+ cell numbers before and after antigen-specific expansion/induction by oral antigen  
  Input of Foxp3+ cells  Foxp3+ recovered after 6 days of OVA-feeding 
  transferred   livLN mLN 
Precursor 
cells 
 
Foxp3+  
(%)a 
Cell number 
(x 103)b 
 
Foxp3+ 
(%)c 
Cell number 
(x 103)d 
Foxp3+ 
(%)c 
Cell number 
(x 103)d 
αE
-CD25-  0.19 6.2  24.6 ± 3.3 1.2 ± 0.5 9.4 ± 1.1 37 ± 6.1 
αE
-CD25+  92 347  98.5 ± 0.5 2.3 ± 1.3 97.1 ± 2.0 26.6 ± 4.9 
aFrequency of Foxp3+ cells among CD4+KJ1.26+ DO11.10 cells transferred into BALB/c recipients. 
bCell number of Foxp3+ cells among CD4+KJ1.26+ DO11.10 cells transferred into BALB/c recipients. 
cMean frequency ± SD of Foxp3+ cells among CD4+KJ1.26+ recovered from BALB/c recipients (n=3-4). 
dMean cell number ± SD of Foxp3+ cells among CD4+KJ1.26+ recovered per LN (n=3-4). 
 
Taken together the present data suggest that αE identifies Foxp3+ Tregs, which have expanded in the 
periphery under non-inflammatory conditions. This subset of naturally occurring Tregs represents a 
population of heterogeneous origin containing cells differentiated from thymic-derived CD25+ Tregs 
as well as de novo induced Tregs, which have converted from the conventional T cell pool.  
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3.2 Induction of gut-specific homing receptor expression on Foxp3+ Tregs 
The aim of the second part of this study was to investigate how Tregs acquire the expression of 
homing receptors needed for tissue- or inflammation-specific migration. It was not known whether 
they respond in a similar way as conventional naïve T cells to signals instructing tissue-specific 
homing receptor expression and organ-selective trafficking. Therefore, the susceptibility of naïve 
Tregs to acquire homing receptor expression under defined in vitro culture conditions was investigated 
and the functionality of the induced phenotype was tested upon adoptive transfer.  
 
3.2.1 Induction of gut-specific homing receptors by tissue-specific DCs 
Tissue-specific DCs have been shown in a number of in vitro and in vivo studies to be involved in the 
instruction of naïve T cells (Annacker, et al., 2005; Dudda and Martin, 2004; Dudda, et al., 2004; 
Johansson-Lindbom, et al., 2005; Johansson-Lindbom, et al., 2003; Mora, et al., 2003; Mora and von 
Andrian, 2006; Stagg, et al., 2002). In order to investigate whether organ-selective homing receptors 
are induced on Tregs in a similar fashion, in vitro culture systems were set up using freshly isolated 
DCs and sorted naïve CD25+ Tregs. To overcome the hyporesponsiveness of Tregs, high doses of 
exogenous IL-2 were added during antigen-specific activation.  
CD11c+ DCs from mLNs and pLNs were isolated and co-cultured with naïve CD4+CD25+ Tregs from 
OVA-specific TCR-tg mice in the presence of OVA323-33 peptide. Naïve Tregs were used, which 
typically display low levels of α4β7 and lack P-Lig expression (Huehn, et al., 2004), to exclude Tregs 
that already have been imprinted for these homing receptors within donor mice. On day 4 cultured 
CD4+ Tregs were harvested and analysed by flow cytometry for expression of the gut-specific homing 
receptors α4β7 and CCR9 as well as for homing receptors associated with skin-specific migration, P-
Lig and E-Lig. In Figure 15 representative results from flow cytometric analyses are shown. Tregs 
cultured in the presence of mLN-derived DCs homogeneously expressed high levels of α4β7, whereas 
only a minor fraction of Tregs cultured with pLN-derived DCs showed intermediate α4β7 expression. 
CCR9 expression was not induced under these culture conditions, neither by mLN-derived DCs nor by 
pLN-derived Dcs. In contrast, P-Lig expression was observed on Tregs from co-cultures with both 
mLN- and pLN-derived DCs, while the latter induced slightly enhanced frequencies. Selective 
differences were observed with respect to expression of E-Lig, which was induced on a fraction of 
Tregs cultured in the presence of pLN-derived DCs, while no induction occurred in mLN-derived DC 
co-cultures (Figure 15). These results indicated that naïve CD25+ Tregs responded in a similar manner 
to tissue-specific factors mediated by organ-specific DCs as has been previously reported for 
conventional T cells. 
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Figure 15: Induction of homing receptor expression on Tregs cultured with organ-specific DCs 
Organ-specific DCs were isolated by magnetic enrichment of CD11c+ cells from single cell suspensions of pLN 
and mLN, respectively (2.2.2.4). Naïve CD25+CD4+CD62Lhigh were isolated from pooled LNs and spleens of 
DO11.10 mice by magnetic enrichment of CD25+ cells and subsequent FACSorting of CD4+CD62Lhigh cells 
(2.2.2.3). Purified CD4+CD25+CD62Lhigh Tregs were labelled with CFSE and stimulated for 4 days with OVA323-33 
peptide and high dose IL-2 in the presence of CD11c+ DCs derived from mLN and pLN, respectively. (a) Dot plots 
show CFSE vs. staining for α4β7, CCR9, P-Lig and E-Lig (right panel) on cultured Tregs after 4 days of antigen-
specific activation with tissue-specific DCs. Control stainings are depicted in the left panel. (b) GMFI of α4β7 
expression of the whole population, frequency of CCR9+, P-Lig+ and E-Lig+ cells. Data points represent 
independent experiments except for E-Lig (dublicate analysis from one experiment), lines indicate the median. 
* p < 0.05. 
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3.2.2 Induction of gut-specific homing receptors by soluble factors 
In addition to co-cultures with tissue-specific DCs, DC-free stimulation systems using plate-bound 
anti-CD3 and anti-CD28 mAbs were established to induce expression of organ-selective homing 
receptors on Tregs. As polarising compounds, RA and IL-12 were used, which have been shown to 
induce α4β7 and P-Lig on activated T cells, respectively (Austrup, et al., 1997; Iwata, et al., 2004). In 
vitro activation of naïve CD25+ Tregs in the presence of RA induced high α4β7 levels on Tregs (Figure 
16a). In contrast, only very weak α4β7 levels were observed upon activation under neutral conditions 
or upon addition of IL-12. Similarly, expression of CCR9 was selectively induced on a fraction of 
Tregs in cultures containing RA, but not IL-12. A different picture was observed with respect to the 
expression of P-Lig. Whereas culture of naïve CD25+ Tregs under neutral conditions only slightly 
enhanced P-Lig expression, a large fraction of cells cultured in the presence of IL-12 acquired P-Lig 
expression. However, also in vitro culture in the presence of RA led to induction of P-Lig on a 
significant fraction of Tregs. In contrast, in cultures of conventional CD4+CD25- T cells P-Lig 
expression was differentially regulated, here only IL-12 led to significant frequencies of P-Lig+ cells. 
Expression of E-Lig was consistently induced upon addition of IL-12 on fractions of both CD25+ 
Tregs and CD25- T cells and was efficiently suppressed in RA cultures, as reported previously (Iwata, 
et al., 2004) (Figure 16a). 
In summary, Tregs were found to respond by and large similar to tissue-specific signals as 
conventional T cells, and were sensitive to selective induction of organ-specific homing receptors in 
response to appropriate stimuli. 
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Figure 16: Induction of homing receptor expression on Tregs cultured under polarising conditions 
Naïve CD4+CD25+CD62Lhigh and CD4+CD25-CD62Lhigh cells were isolated from pooled LNs and spleens of 
BALB/c mice by a combination of MACS and FACS (2.2.2.3). Purified T cells were labelled with CFSE and 
stimulated on anti-CD3/CD28 coated plates under neutral or polarising conditions in the presence of RA and IL-12, 
respectively. (a) Dot plots show representative results of CFSE vs. staining for α4β7, CCR9, P-Lig and E-Lig on 
cultured Tregs (CD25+) and conventional naïve T cells (CD25-) after 6 days of polyclonal activation under 
indicated conditions. (b) GMFI of α4β7 expression of the whole population, frequency of CCR9+, P-Lig+ and 
E-Lig+ cells. Single data points represent independent experiments, lines indicate the median. * p < 0.05; 
** p < 0.01. 
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3.2.3 Phenotype and function of in vitro modulated Tregs 
An important prerequisite for potential therapeutic use of in vitro expanded Tregs, is maintenance of 
their characteristic features. Therefore, Tregs skewed to tissue-specific homing receptor expression in 
vitro were tested for their suppressive activity. The vast majority of Tregs expanded under any 
condition - neutral, RA or IL-12 - maintained high frequencies of Foxp3+ cells (Figure 17). The 
highest frequency was consistently observed within RA-cultured Tregs. More importantly, when 
tested in an in vitro proliferation assay with CFSE-labelled CD25-CD4+ naïve target T cells, all Tregs 
expanded for 6 days under different conditions similarly suppressed naïve CD4+ T cell proliferation 
indicating that cultured Tregs maintained high suppressive capacity after the culture period (Figure 
18). 
 
 
Figure 17: In vitro polarised Tregs maintain Foxp3 expression 
Naïve CD4+CD25+CD62Lhigh Tregs were stimulated on anti-CD3/CD28 coated plates under neutral or polarising 
conditions for 6 days as described in Figure 16 and analysed for expression of Foxp3. Histograms show 
representative staining for Foxp3 (filled) on Tregs before and after culture under respective conditions. Numbers 
indicate the frequency of Foxp3+ cells. As control, Foxp3 staining of naïve CD4+CD25- T cells is shown (grey line, 
upper histogram). Data points represent the frequency of Foxp3+ cells among cultured CD25+ Tregs from 
independent experiments, lines indicate the median. * p < 0.05. 
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Figure 18: In vitro polarised Tregs maintain suppressive capacity  
Naïve CD4+CD25+CD62Lhigh Tregs were stimulated on anti-CD3/CD28 coated plates under neutral or polarising 
conditions for 6 days as described in Figure 16 and used for co-cultures with CFSE-labelled naïve CD4+CD25-
CD62Lhigh responder T cells at a ratio of 1:2 in the presence of CD90-depleted APCs and anti-CD3 for 3 days. 
Proliferation of naïve responder cells was evaluated according to CFSE dilution. (a) Histograms show CFSE-
staining of responder T cells alone (left) or in the presence of cultured CD25+ Tregs (right). The GMFI of the 
CFSE+ fraction (dotted line) is indicated. (b) GMFI of CFSE+ cells (mean ± SD, from triplicate measurements) 
from naïve responder cells cultured under indicated conditions. Representative data from one out of three 
independent experiments with similar results are depicted. 
 
3.2.4 Migratory behaviour of in vitro modulated Tregs 
Having confirmed that expansion and modulation of Tregs in vitro did not alter their characteristic 
features, while at the same time conveying selective homing phenotypes, the functionality of the 
newly achieved homing receptors remained to be tested. Therefore, Tregs that had been cultured under 
neutral or polarising conditions in the presence of RA and IL-12, respectively, were analysed for their 
migration behaviour in vivo in a DTH footpad inflammation model (Feuerer, et al., 2006; Siegmund, et 
al., 2005). Cultured Tregs were radioactively labelled and injected i.v. into mice, in which 24h before 
the DTH response had been induced. At his time point acute inflammation in the footpad had reached 
its maximum and thus allowed to monitor recruitment of transferred Tregs into a peripheral site of 
inflammation. One day after transfer, the migration of Tregs was determined by measuring the 
distribution of radioactivity in individual organs. Tregs cultured in the presence of RA showed 
preferential migration into the gut (small and large intestine) as well as into mLNs and PPs, supporting 
previous findings that expression of α4β7 enabled entrance into these compartments (Hamann, et al., 
1994; Holzmann and Weissman, 1989). RA-cultured Tregs were barely detected in the inflamed 
footpad. In contrast, Tregs that had been expanded in the presence of IL-12 efficiently migrated into 
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the inflamed footpad. This inflammation-seeking capacity was significantly higher compared to Tregs 
cultured under neutral conditions or in the presence of RA (Figure 19). Clearly, Tregs cultured in the 
absence of polarising factors did not display distinct organ-specific migration behaviour. They did not 
enter the inflamed footpad very effectively and were recruited less efficiently into the gut and GALT. 
Distribution of differentially cultured Tregs throughout other organs, i.e. spleen, lung and liver was 
similar. These findings provided evidence that in vitro modulation of naïve-like Tregs resulted in the 
induction of functional organ-selective homing receptors allowing efficient migration of polarised 
Tregs into mucosal and inflamed tissues, respectively.  
 
 
 
Figure 19: In vivo migration potential of in vitro polarised Tregs. 
Naïve CD4+CD25+CD62Lhigh Tregs were stimulated on anti-CD3/CD28 coated plates under neutral or polarising 
conditions for 6 days as described in Figure 16. Cultured Tregs were harvested, radioactively labelled with 111In as 
described in 2.2.5.5 and adoptively transferred into recipient mice bearing an acute skin inflammation in one 
footpad (DTH). Distribution and migratory behaviour of Tregs cultured under the indicated conditions was 
analysed 24h after adoptive transfer by determining the amount of radioactivity recovered from indicated organs 
using a γ-counter. Bars display mean ± SD from 6 individual mice and are representative of two independent 
experiments. * p < 0.05; **p < 0.01. 
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4 Discussion 
Tregs are increasingly recognised as a major cell population involved in the regulation of numerous 
immune responses. Their mode of action ranges from the suppression of onset of disease in the local 
LNs to amelioration of established effector responses directly at the site of inflammation. Consistent 
with these observations and the numerous disease models describing a role for Tregs, the phenotype 
and function of Treg populations were found to be highly diverse. Our group focused on a distinct 
subset of naturally occurring Tregs characterised by the expression of the integrin αE. At the beginning 
of this study it was recognised that αE identified Tregs with an activated, highly differentiated 
phenotype. These αE+ Tregs were found to be equipped with adhesion molecules and chemokine 
receptors allowing their efficient migration into peripheral, non-lymphoid sites. How and where these 
effector/memory-like αE+ Tregs were generated in vivo was not known. Furthermore, it was not known 
whether Tregs could be modulated in vitro in order to acquire distinct sets of adhesion molecules 
conveying targeted migration upon adoptive transfer.  
 
4.1 αE identifies effector/memory-like Tregs with high proliferative activity 
Expression of αE on Foxp3+ Tregs correlates with an effector/memory-like phenotype 
In this study previous findings regarding the phenotype of αE+ Tregs were confirmed and extended by 
direct correlation of their phenotypic key features to intracellular expression of Foxp3. The results 
obtained from co-staining with Foxp3 corroborated the differential expression of CD62L and CD44 on 
αE
-CD25+, αE+CD25+ and αE+CD25- Treg subsets, respectively, and the association of an 
effector/memory-like phenotype with expression of αE.  
In addition to these αE/CD25 subsets, Foxp3+ cells were also detected in a small fraction of the 
αE
-CD25- population. The existence of CD25lowFoxp3+ Tregs was first reported by Fontenot and 
colleagues, who generated GFP knock in mice expressing a GFP-Foxp3 fusion-protein under the 
control of the Foxp3 promoter. This allowed thorough analysis of the correlation between CD25 and 
Foxp3GFP+ cells. Global gene analysis of the two Foxp3+ populations revealed that CD25lowFoxp3+ 
expressed higher levels of genes associated with regulatory effector functions and tissue migration 
than CD25highFoxp3+. In addition, the CD25lowFoxp3+ population was enriched for cells displaying an 
activated surface phenotype and for proliferating Ki67+ cells (Fontenot, et al., 2003). Our data extent 
these findings and indicate that the observed characteristics of the CD25lowFoxp3+ may be attributed 
largely to the αE+CD25-Foxp3+ subset, while both the αE+CD25+Foxp3+ and αE-CD25-Foxp3+ subsets 
displayed intermediate activation/differentiation levels.  
Taken together, these results further support the concept of a division of labour between distinct sets 
of naturally occurring Foxp3+ Tregs in the healthy un-manipulated host (Huehn and Hamann, 2005) 
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and confirm that the combined use of the markers CD25 and αE may be helpful in identification of 
these different Foxp3+ Treg subsets.  
 
4.1.1 Peripheral proliferation of Tregs in thymectomised mice 
One major characteristic of Tregs, observed during initial studies, was their inability to proliferate 
under standard in vitro conditions. While they required TCR-mediated activation, only addition of 
exogenous IL-2 was able to overcome the anergic state of Tregs (Thornton and Shevach, 1998). In 
contrast, strong proliferation in vivo, i.e. in LNs draining tissue that expresses their respective self-
antigen was demonstrated in subsequent studies (Fisson, et al., 2003; Klein, et al., 2003; Walker, et al., 
2003).  
Here, the correlation of αE expression and peripheral proliferation of Tregs in thymectomised mice in 
the steady state was analysed. Dividing cells were highly enriched in the αE+CD25- fraction, to a lesser 
extent in the αE+CD25+ Treg subset and the lowest fraction of proliferating cells was found within the 
αE
-CD25+ Treg subset. These findings demonstrated a clear link between high proliferative activity 
and the effector/memory-like phenotype of αE+ Tregs as previously hypothesised (Huehn, et al., 2004). 
The observed proliferation indicates that a major part of Tregs is constantly cycling under steady state 
conditions, presumably in response to their cognate antigen. These findings are in accordance with 
results from Fisson and colleagues, who demonstrated rapid turnover of adoptively transferred 
polyclonal CD4+CD25+CD62Lhigh Tregs in non-lymphopenic recipients associated with acquisition of 
an activated phenotype (Fisson, et al., 2003). Based on the CFSE profile of transferred Tregs, these 
authors observed loss of CD62L expression and up-regulation of CD44 only on those cells that had 
undergone several rounds of division. In addition, they demonstrated that incorporation of BrdU was 
restricted to a major fraction of CD25+CD44high Tregs. Our study extends these findings by examining 
more closely the contribution of different naturally occurring Treg subsets to peripheral proliferation 
under steady state conditions. A proliferative response of CD25+ Tregs in vivo was also observed in 
the presence of cognate antigen in studies using TCR-tg models. Proliferation was found to occur both 
under non-inflammatory conditions in response to tissue-restricted expression of the respective antigen 
(Cozzo, et al., 2003; Fisson, et al., 2003; Green, et al., 2002) as well as upon immunisation with 
cognate antigen and IFA (Klein, et al., 2003; Walker, et al., 2003), supporting the notion that Treg 
proliferation requires antigen-specific activation.  
In the polyclonal repertoire the nature of these antigens remains elusive, although, it was shown that 
Tregs display a diverse TCR repertoire (Takahashi, et al., 1998), which is distinct from conventional T 
cells and skewed towards high affinity recognition of self-antigen (Hsieh, et al., 2004; Nishikawa, et 
al., 2005). Furthermore, Tregs and potentially pathogenic self-reactive T cells were found to have 
intersecting TCR repertoires (Hsieh, et al., 2006). Nevertheless, one recent report by Suffia and 
colleagues provided evidence for specific reactivity towards foreign antigen in a model of Leishmania 
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major infection. These authors concluded that parasite-specific recognition was essential for expansion 
and function of responding Foxp3+ Tregs (Suffia, et al., 2006). In addition, data from gnotobiotic mice 
obtained in this study suggest a contribution of stimuli derived from the intestinal microflora on the 
proliferation of Tregs (see below).  
Collectively, the above findings indicate that under steady state conditions sufficient antigen sources 
exist stimulating homeostatic proliferation of Tregs in healthy mice. Clearly, the results from this 
study show that the highest proliferative activity accumulates in the Treg subsets, which display an 
effector/memory-like phenotype and are characterised by the expression of αE. 
 
αE
+ Treg numbers are independent of thymic output 
Compared to untreated controls, thymectomised mice displayed a relative increase in the frequency of 
αE-expressing Tregs, which was due to the reduced cell count of conventional CD4+ T cells resulting 
in a mild lymphopenia of the T cell compartment. Absolute numbers of αE+ Treg were comparable to 
non-thymectomised control mice, indicating that thymic export was not necessary to maintain this 
Treg subset. In contrast, the αE-CD25+ Tregs displayed an equal reduction in cell numbers following 
thymic ablation as the conventional, naïve T cell pool. These findings support a concept, where αE 
identifies peripherally expanded effector/memory-like Tregs, which possibly have differentiated from 
naïve-like αE-CD25+ Tregs. The data obtained here are in line with a previous report by Dujardin et al, 
who demonstrated a pronounced predominance of αE+CD25+ Tregs in adult mice that had been 
thymectomised at day 3 (d3Tx) (Dujardin, et al., 2004). In newborn mice αE+CD25+ Tregs were barely 
detected, while significant numbers of αE-CD25+ Tregs had already emigrated from the thymus before 
thymectomy. In contrast, adult d3Tx mice showed 5-fold higher frequencies of αE+CD25+ Tregs 
compared to non-thymectomised control mice. These authors suggested that the αE+CD25+ population 
had expanded from thymic-derived αE-CD25+ Tregs upon exposure to peripheral antigen. Our study 
using mice thymectomised at the age of three weeks, demonstrates that independence of αE+ Tregs 
from thymic output is not restricted to a situation where postnatal development of the whole T cell 
compartment is severely disturbed.  
 
4.1.2 Peripheral proliferation in gnotobiotic mice 
Tregs are believed to contribute constantly to the maintenance of immune homeostasis and prevention 
of undesired responses to self (Sakaguchi, 2004). Most importantly, the presence of the respective 
antigen is required for survival and function of Tregs (Garza, et al., 2000; Jordan, et al., 2001; 
Nishikawa, et al., 2005; Seddon and Mason, 1999; Walker, et al., 2003).  
Apart from responses to self-antigens, constant encounters with dietary and microbial antigens at 
mucosal surfaces require regulatory mechanisms, which also include the action of various intestinal 
Treg subsets (reviewed in (Mowat, 2003; Rook and Brunet, 2005)). A role for Tregs in the regulation 
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of gut-associated immune responses has been postulated for some time (Cong, et al., 2002; 
Duchmann, et al., 1996; Gad, et al., 2004; Khoo, et al., 1997) and break of tolerance towards the 
intestinal microflora is believed to be the major cause of inflammatory bowel disease (Duchmann, et 
al., 1995). However, the impact of a complex intestinal microflora on the Foxp3+ Treg compartment 
has not been sufficiently addressed to date. Here it was found that both numbers and relative 
proportion of CD4+Foxp3+ Tregs were substantially regulated by the presence of microbial stimuli. 
Under steady state conditions Tregs proliferated vigorously in GALT of SPF mice, while these 
responses were significantly reduced upon depletion of the commensal flora. These results suggest 
that local expansion in GALT influences overall Treg numbers and thereby, contributes to Treg 
homeostasis under non-inflammatory conditions.  
 
Foxp3+ Treg numbers are decreased upon depletion of intestinal bacteria  
Upon eradication of the intestinal microflora, treated mice acquired a reduction of the whole 
lymphocyte compartment. The decrease also included all Foxp3+ Treg subsets. This suggested that the 
overall number of Foxp3+ Tregs was influenced by the presence or absence of intestinal flora. Whether 
this was mediated by direct recognition of bacterial antigen or rather a consequence of cross-
presentation of self-antigen by bacterial-activated APCs, remains currently unknown. These scenarios 
are not mutually exclusive and would equally result in reduced proliferation of the responding Tregs 
upon removal of the bacterial stimuli.  
It was found here that αE-expressing Treg subsets were much more reduced in their absolute cell 
number by depletion of commensal bacteria than the naïve-like αE-CD25+ subset and that on the 
contrary, the frequency of the latter was even relatively increased among all Foxp3+ Tregs. These data 
support the hypothesis, that maintenance of αE+ Tregs depends more on the presence of peripheral 
stimuli driving activation and proliferation of Tregs. In contrast, naïve-like αE-CD25+ Tregs appear to 
rely much more on other factors i.e. thymic export for homeostatic balance. The αE-CD25-Foxp3+ Treg 
subset was found to display an almost similar proliferative activity as the αE+CD25-Foxp3+ Tregs 
consistent with the increased frequency of Ki67+ cells within CD25loFoxp3gfp+ Tregs reported earlier 
by Fontenot and colleagues  (Fontenot, et al., 2005). However, if and how these CD25- Treg subsets 
are related to each other is currently unknown. Clearly, αE-CD25- cells exceeded αE+CD25- cells and 
were similar to αE+CD25+ cells both in number and frequency among CD4+Foxp3+ Tregs in healthy 
mice. Taken together these data indicate that αE-expression and/or lack of CD25-expression identifies 
three subsets of Foxp3+ Tregs, which show enhanced proliferation and activated phenotypes compared 
to the naïve-like αE-CD25+ Tregs.  
 
Antigen-specific recognition of bacterial antigen by Tregs? 
As mentioned above the nature of the interaction of Tregs with commensal bacteria is unknown. 
Several scenarios can be envisioned: 1) Tregs, though selected in the thymus towards the recognition 
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of self-antigen could cross-react to environmental antigen, which as a consequence would initiate 
activation, expansion and differentiation of the cross-reactive Tregs as suggested by Belkaid et al. 
(Belkaid, et al., 2006; Suffia, et al., 2006). 2) The repertoire of Tregs may indeed be strictly self-
reactive and peripheral activation may occur solely in the presence of the respective self-antigen. 
Nevertheless, environmental antigen could indirectly activate proliferation of Tregs when presented on 
activated APCs together with the respective self-antigen. Release of self-antigen would be increased 
during acute inflammation due to tissue-damage. 3) Response to bacterial compounds could be 
mediated by receptors directly sensing the presence of pathogen associated molecular patterns. 
Distinct Toll-like receptors (TLR) are selectively expressed by Tregs (Caramalho, et al., 2003) and 
recognise i.e. bacterial LPS, CpG-DNA or peptidoglycan. Ligand interaction with TLRs was shown to 
influence the suppressive activity of Tregs (Kubo, et al., 2004; Pasare and Medzhitov, 2003) and to 
induce expansion of Tregs in vitro even in the absence of additional TCR-stimulation (Liu, et al., 
2006; Sutmuller, et al., 2006). 
None of these interactions are mutually exclusive and clearly provide a basis to explain the effect of 
the presence or absence of intestinal bacteria on the number and the proliferative activity of Foxp3+ 
Tregs demonstrated in this study. The impact of individual mechanisms on the peripheral expansion of 
Tregs will have to be dissected in future studies.  
 
A matter of homeostatic equilibrium? 
The observed decreases of both Treg numbers and in vivo proliferation in GALT upon depletion of 
commensal flora favour the view of a direct interaction between intestinal bacterial stimuli and Foxp3+ 
Tregs, either by antigen-specific or through bystander activation. However, another interpretation of 
the present data could be a strict regulation of the homeostatic balance between conventional T cells 
and Tregs. Such regulation would imply that only as many Tregs are maintained under steady state 
conditions as are required for suppression of potentially harmful immune responses to peripheral 
antigens. Such a balance could be regulated via the production of IL-2, which is indispensable for 
maintenance of peripheral Tregs (Bayer, et al., 2005; D'Cruz and Klein, 2005; Fontenot, et al., 2005; 
Furtado, et al., 2002; Malek and Bayer, 2004; Sadlack, et al., 1995; Schorle, et al., 1991; Setoguchi, et 
al., 2005; Suzuki, et al., 1995; Willerford, et al., 1995). Tregs themselves are not capable to produce 
IL-2 and therefore crucially depend on paracrine IL-2 for their survival and expansion in the 
periphery. While certain DCs may represent one possible cellular source of IL-2 (Granucci, et al., 
2001), more likely, activation and IL-2 production by conventional CD4+ T cells supply the survival 
factors for Tregs (Setoguchi, et al., 2005). This provides a feed back loop, which links the number and 
proportion of Foxp3+ Tregs directly to the number of IL-2 producing T cells as recently proposed by 
Almeida and colleagues (Almeida, et al., 2006). In the absence of activating signals from microbial 
antigen the reduction of conventional T cell produced IL-2 would then lead to reduced numbers and 
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proliferation of Tregs and thereby regulate the homeostatic equilibrium of these two T cell subsets to 
each other.  
Based on the finding that IL-2 is not essential for thymic development of Foxp3+ Tregs, while it is 
required for an adequate size of the Treg cell population in the periphery (Fontenot, et al., 2005), 
reduced IL-2 production by conventional T cells in the absence of intestinal stimuli should much more 
affect the number of Treg subsets associated with homeostatic expansion. Consistent with this idea, 
our finding that the proportion of naïve-like αE-CD25+ Tregs was increased among CD4+Foxp3+ cells 
after eradication of the intestinal microflora supports the notion that this population relies more on 
thymic export than on homeostatic expansion/survival. In contrast, the generation of effector/memory-
like αE+ Tregs may respond much more sensible to the presence or absence of survival factors like 
IL-2 leading to reduced peripheral proliferation and a decrease in population size.    
 
4.2 Generation of effector/memory-like Tregs in vivo 
Differentiation of naïve-like CD25+ Tregs into αE+ Tregs 
The majority of naturally occurring Foxp3+ Tregs are thought to originate from the thymus, where 
they are generated as a distinct lineage, which is selected towards recognition of self-antigen. The 
absolute contribution of these thymic-derived Tregs to the peripheral pool of Foxp3+ Tregs is currently 
unknown. In order to clarify the developmental relationship between the different naturally occurring 
Foxp3+ Treg subsets, this part of the project aimed to identify the precursor of the αE-expressing Treg 
subset. When OVA-specific naïve-like αE-CD25+ Tregs were transferred, followed by oral antigen 
administration, the vast majority of CD25+ Tregs previously negative for αE up-regulated expression 
of this marker, suggesting that tolerogenic, antigen-specific activation of naïve-like Tregs led to 
proliferation, differentiation and acquisition of an effector/memory-like phenotype. Under these 
conditions, transferred CD25+ Tregs maintained high levels of Foxp3 and CD25 expression.  
Earlier studies in rats already indicated a requirement for access to the respective auto-antigen for 
survival and function of Tregs, suggesting self-antigen-driven expansion in the periphery (Seddon and 
Mason, 1999). Direct evidence for proliferation of CD25+ Tregs in vivo upon antigen-specific 
activation was provided in subsequent studies (Fisson, et al., 2003; Klein, et al., 2003; Walker, et al., 
2003). Proliferation depended on the presence of antigen within the local environment and 
consequently, was restricted to LNs draining the site of tissue-expression or antigen-uptake. The 
kinetics of the antigen-specific proliferative response of CD25+ Tregs were found to be similar to 
those of CD25- cells activated under the same conditions in vivo (Klein, et al., 2003). While no 
correlation with the expression of αE was included in these studies, the present data confirm and 
extend the previous findings by demonstrating a close link between tolerogenic activation of naturally 
occurring Tregs and induction of an effector/memory-like phenotype characterised by αE-expression.  
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De novo induction of αE+Foxp3+ Tregs 
When conventional, naïve αE-CD25-Foxp3-CD62Lhigh DO11.10 T cells were transferred and subjected 
to the same regimen of antigen administration, induction of Foxp3+ cells in a dose-dependent fashion 
was observed. Induction of Foxp3+ cells was most prominent in the livLN, where basically all cells 
acquired Foxp3 expression after two rounds of division, while undivided cells only partially up-
regulated Foxp3. Several studies have demonstrated the conversion of non-regulatory, conventional T 
cells into Tregs under distinct conditions in vivo, both by using TCR-tg (Apostolou and von Boehmer, 
2004; Cobbold, et al., 2004; Hultkrantz, et al., 2005; Kretschmer, et al., 2005; Mucida, et al., 2005; 
Thorstenson and Khoruts, 2001) and polyclonal naïve precursor cells (Curotto de Lafaille, et al., 2004; 
Liang, et al., 2005).  
One of the first studies to show the emergence of CD4+CD25+ upon i.v. injection of peptide or oral 
protein administration, employed adoptive transfer of OVA-specific DO11.10 CD25- cells from mice 
on a RAG-2-/- background (DORAG) (Thorstenson and Khoruts, 2001). In contrast to DO11.10 mice, 
DORAG mice do not contain CD25+ Tregs (Itoh, et al., 1999) and therefore, use of these mice 
excluded the potential outgrowth of pre-existing CD25+ Tregs and clearly demonstrated the capacity to 
induce Tregs de novo under appropriate conditions in vivo. Apostolou and colleagues used low dose 
s.c. peptide administration via implanted osmotic pumps and could demonstrate that under these 
conditions CD25+Foxp3+ Tregs were generated in thymectomised TCR HA tg RAG-2-/- mice in the 
absence of overt activation and proliferation (Apostolou and von Boehmer, 2004). Another study from 
this group followed a different approach by targeting DCs with a specific antibody (DEC205) coupled 
to the cognate antigen and demonstrated that transferred TCR HA tg RAG-2-/- cells acquired 
expression of Foxp3 in a dose- and proliferation-dependent manner (Kretschmer, et al., 2005). Mucida 
et al. stated that induction of CD4+CD25+Foxp3+ Tregs was possible upon oral antigen administration 
in a mouse strain containing HA-monospecific B cells and OVA-monospecific T cells on a RAG-1-/- 
background (T/B monoclonal). Devoid of thymic-derived Tregs newly generated Tregs were able to 
prevent subsequent allergic responses towards OVA-HA immunisation (Mucida, et al., 2005). A 
different experimental set up used the same T/B monoclonal mice as recipients of BALB/c polyclonal 
CD4+CD25- T cells. Lymphopenia-driven proliferation equally led to the generation of donor-derived 
CD4+CD25+ Tregs expressing high levels of Foxp3 mRNA (Curotto de Lafaille, et al., 2004). 
Similarly, Liang and colleagues showed induction of polyclonal CD4+CD25+Foxp3-mRNA+ Tregs. A 
fraction of C57BL/6 CD4+CD25- T cells transferred into congenic recipients converted into a 
phenotype indistinguishable from naturally occurring Tregs upon peripheral proliferation in sub-
lethally irradiated and non-irradiated hosts. These authors reported that the conversion was 
independent of the thymus but required co-stimulation via Β7 (Liang, et al., 2005).  
The data from our study are in line with the above findings, however here the de novo induction of 
Foxp3 upon oral antigen administration was directly visualised on the single cell level. This provides 
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conclusive evidence that conversion of naïve CD4+ T cells into a phenotype that is indistinguishable 
from natural CD25+Foxp3+ Tregs can occur in mucosal tissues under tolerogenic conditions. 
 
Expression of αE was analysed in some studies and detected on a fraction of converted CD25+ Tregs 
similar to frequencies observed on naturally occurring CD25+Foxp3+ Tregs (Curotto de Lafaille, et al., 
2004; Liang, et al., 2005). Hultkrantz and colleagues described an important role for the livLN in the 
generation of CD25+ Tregs, characterised by high co-expression of αE and suppressive capacity 
(Hultkrantz, et al., 2005). However, the authors did not detect Foxp3 mRNA in this subset. In contrast, 
in our study expression of both  αE and Foxp3 was consistently observed on the single cell level. The 
periportal livLN drains the liver, stomach and pancreas (Matsuno, et al., 1990) and several studies 
have shown an important role for the liver in generating tolerogenic immune responses to food antigen 
and even in transplantation settings (Knolle, 2006; May, et al., 1969). Antigen from the intestinal 
lumen reaches the liver directly via the portal vein and occlusion of the portal vein prevented the 
development of oral tolerance (Yang, et al., 1994). De novo induction of Foxp3+ Tregs in the livLN 
upon oral antigen administration found here underlines a pivotal role for the livLN in the induction for 
periperal tolerance. 
 
Foxp3+ Tregs develop from naïve CD4+ T cells  
The data presented here indicated that Foxp3+ Tregs could be generated by conversion of previously 
Foxp3- non-regulatory T cells. That this was not due to selective outgrowth or survival of small 
numbers of contaminating Foxp3+ T cells was concluded from the following findings: 1) Up-
regulation of Foxp3 occurred even on a part of the non-divided CFSEhigh fraction of transferred cells, 
but only in the presence of cognate antigen. This argues against selective outgrowth of the pre-existing 
0.12% of Foxp3+ cells. 2) The absolute cell numbers recovered after transfer of either 6.2 x 103 CD25-
Foxp3+ cells or 3.5 x 105 CD25+Foxp3+ clearly contradicted the possibility that appearance of Foxp3+ 
Tregs in recipients of CD25- cells was due to expansion from the pre-existing contaminating CD25-
Foxp3+ subset. Otherwise a dramatically increased expansion and/or survival rate (30 to 70-fold) 
would have to be assumed compared to the situation where CD25+Foxp3+ had been transferred. 
Although this scenario cannot be formally excluded, it appears to be highly unlikely and was also 
disproved in a study by Liang and colleagues (Liang, et al., 2005). Therefore, based on these findings 
we concluded that Foxp3+ Tregs were induced from the non-regulatory CD62Lhigh T cell pool in 
response to the particular conditions of antigen-specific activation, predominantly in the livLN, 
following oral administration of cognate antigen. 
 
A role for TGF-β in generation of αE+Foxp+ Tregs in vivo? 
It is tempting to speculate that TGF-β might be a major factor driving generation of Foxp3+ cells in the 
setting described here. Several in vitro data have shown induction of Foxp3 upon stimulation in the 
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presence of TGF- β (Chen, et al., 2003; Fantini, et al., 2004). Furthermore, TGF-β is important for 
maintenance of Foxp3 expression and suppressive function of Tregs in vivo (Huber, et al., 2004; 
Marie, et al., 2005). Protection from disease in NOD mice was associated with expansion of Foxp3+ T 
cells in the draining LN following transient over-expression of TGF-β in the islets (Peng, et al., 2004). 
On the other hand, de novo generation of CD4+CD25+Foxp3+ Tregs in vivo was reduced or completely 
inhibited by administration of blocking anti-TGF-β mAbs during tolerance induction to skin grafts 
under the cover of anti-CD4 mAb treatment (Cobbold, et al., 2004), when targeting DEC205+ DCs 
(Kretschmer, et al., 2005) or during oral antigen administration (Mucida, et al., 2005). Taken together, 
these findings clearly indicate a role for TGF-β in the induction and maintenance of Foxp3+ cells in 
vivo. Next to these recent results, it has been known for some time that TGF-β is a major factor 
inducing expression of αE on CD4+ T cells (Kilshaw and Murant, 1991). Initial data from our group 
confirmed that in vitro activation of naïve CD4+CD25- T cells in the presence of TGF-β induced co-
expression of both Foxp3 and αE (data not shown). However, expression of Foxp3 upon in vitro 
stimulation was not stable and associated with poor demethylation of a conserved promoter element in 
the foxp3 locus in contrast to CD4+CD25+ displaying a high degree of demethylation of the same 
region (Floess, et al., in press). The stability of Foxp3 expression of in vivo induced Tregs is 
currently unknown.  
Taken together, induction of αE-expression on Tregs may reflect activation in a microenvironment 
where local concentrations of active TGF-β were sufficient to both maintain Foxp3 expression in 
proliferating thymus-derived CD25+ Tregs and to generate new Foxp3+ cells from non-regulatory T 
cells.  
 
αE-expression in chronic infection 
Expression of αE has also been associated in a number of studies with peripherally induced/expanded 
Tregs in infection models. Suffia et al. demonstrated a functional role for αE-expression in the 
retention of Tregs at epithelial sites, where they suppressed the local response to Leishmania major 
and were critically involved in the chronicity of the infection (Suffia, et al., 2005). The Tregs were 
parasite-specific and derived from the naturally occurring Foxp3+ Treg pool. Their proliferation and 
survival depended on the presence of the parasite (Suffia, et al., 2006). Baumgart and colleagues 
demonstrated in a model of Schistosoma mansoni that during the course of the disease Foxp3+ Tregs 
changed their phenotype and acquired increasing frequencies of αE+ cells within the CD4+Foxp3+ Treg 
population, while the overall proportion of Foxp3+ Tregs remained unchanged. Again, the presence of 
these activated Tregs was associated with dampening of the egg-induced inflammation and thus 
contributed to survival of the parasite within the infected host (Baumgart, et al., 2006). A similar 
increase in the frequency of αE+Foxp3+ Tregs during disease progression was observed in a model of 
Heligmosomodes polygyrus infection (S. Hartmann, personal communication).  
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The factors involved in up-regulation of αE during chronic infection are unknown, however, it was 
suggested that the parasites modulate the local environment to favour αE-mediated retention of Tregs 
in the dermis of L. major infected skin. A direct role for TGF-β is currently merely a matter of 
speculation, but expression of αE was enhanced on Tregs isolated from chronically infected mice upon 
culture with L. major-infected DCs in vitro, while the presence of pro-inflammatory stimuli (LPS) 
together with infected DCs down-regulated the αE-expression on Tregs (Suffia, et al., 2005).  
These findings are in line with the results obtained in our study, where tolerogenic activation of 
adoptively transferred naïve-like αE-CD25+ Tregs preferentially led to up-regulation of αE on the 
majority of Tregs, while i.p. immunisation in the presence of LPS was much less effective in this 
respect (data not shown).   
 
Origin of αE+ Tregs in immunocompetent mice  
In summary, the data obtained here support the hypothesis that αEβ7 expression correlates not only 
with an effector/memory-like phenotype of Foxp3+ Tregs, but in addition identifies Tregs that are 
constantly cycling under steady state conditions in healthy mice. The sequence of events as 
hypothesised here postulates that the pool of naïve-like αE-CD25+ Tregs is replenished by constant 
export from the thymus. In the periphery, encounter with cognate antigen (self or cross-reactive non-
self) induces expansion and differentiation of these thymic-derived Tregs into an effector/memory-like 
phenotype characterised by expression of αE. In the absence of thymic production an imbalance 
between input and transition leads to a decrease of the naïve Treg population. In contrast, upon 
reduction of peripheral proliferation and differentiation due to removal of environmental 
antigen/stimuli the balance is skewed towards a relative increase of this population. In line with these 
considerations are the observations made for the effector/memory-like αE+ Treg pool. The size of this 
population is maintained in the absence of thymic export but cell number and proliferation are 
decreased upon removal of microbial antigen/stimuli.  
Furthermore, the results presented here strongly suggest, that the αE+Foxp3+ Treg pool is of diverse 
origin, consisting of both thymic-derived, expanded natural Tregs as well as of de novo generated 
Foxp3+ Tregs, induced upon tolerogenic, antigen-specific activation in distinct anatomical sites of the 
body. These findings further enlarge our understanding of the fundamental aspects of Treg biology 
and support the concept, that Foxp3+ Tregs with a phenotype indistinguishable from the naturally 
occurring Foxp3+ Treg pool can be generated de novo under appropriate conditions of antigen-delivery 
in the periphery, while at the same time the very same conditions promote proliferation/expansion of 
pre-existing natural Tregs. 
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 Figure 20: Origin and development of αE+Foxp3+ Tregs 
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4.3 Selective induction of organ-specific homing receptors on Tregs in vitro 
Based on the general view that suppressive function of Tregs requires direct cell-cell contact or at least 
close proximity, it is conclusive that Tregs should display the same migratory properties as their target 
cells. Further, accumulating evidence suggests that suppression of unwanted immune responses may 
take place not only during initiation of an immune response in secondary lymphoid tissue but also 
during the effector phase directly at peripheral sites of inflammation. As a consequence, appropriate 
migration and localisation of Tregs is a prerequisite for their function in vivo. 
The importance of selective trafficking of Tregs might be concluded from several studies observing 
that naïve CD62LhighCD25+CD4+ Tregs, but not their CD62Llow counterparts and/or occupancy within 
LNs were required for preventing development of diabetes, skin inflammation, graft rejection and 
GvHD (Ermann, et al., 2005; Schwarz, et al., 2004; Szanya, et al., 2002; Taylor, et al., 2004). These 
findings suggest that the ability to home to or reside within peripheral lymphoid tissue was important 
to suppress the onset of disease.  
In contrast, efficiency of Tregs in established disease relied largely on distinct subsets of 
effector/memory-like Tregs and indicated a role for recruitment to peripheral sites of inflammation. 
Some studies demonstrated the importance of distinct Treg subsets selectively expressing 
inflammatory chemokine receptors such as CCR2 and CCR6 (Bruhl, et al., 2004; Kleinewietfeld, et 
al., 2005). Furthermore, previous data from our group showed that deficiency in the expression of 
functional skin-tropic E/P-selectin ligands on Tregs abrogated recruitment of these cells to the 
inflamed skin and thus, their capacity to ameliorate local inflammation (Huehn, et al., 2004; 
Siegmund, et al., 2005). These findings clearly indicated that tissue-specific migration of Tregs was 
crucial for effective function in vivo.   
The use of Tregs for adoptive transfer in various disease models represents an attractive therapeutic 
option. However, due to the low numbers of Tregs that can be isolated from an individual, expansion 
of Tregs in vitro is currently tested as a procedure to reach the numbers potentially necessary for in 
vivo function of transferred Tregs. In this respect, the idea to modulate the homing receptor phenotype 
of isolated Tregs during in vitro culture presented an interesting aspect. Thus, in this part of the study, 
the feasibility of such an approach was tested by culturing ex vivo isolated naïve Tregs under distinct 
tissue-skewing conditions.  
 
Tissue-specific DCs modulate homing receptor expression of CD25+ Tregs 
Extended phenotypic analysis of effector/memory Tregs not only confirmed the increased expression 
of various homing receptors (Huehn, et al., 2004) but indicated also that effector/memory Tregs 
displayed a high degree of compartmentalisation under steady state conditions. Cells expressing the 
mucosal homing receptor α4β7 resided predominantly in mLN, whereas cells expressing selectin 
ligands were enriched in pLN (data not shown). These findings indicated a role for the tissue-specific 
microenvironment in the instruction of homing receptor phenotypes on Tregs, similar to results 
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obtained previously for conventional CD4+ T cells (Campbell and Butcher, 2002). Organ-specific DCs 
have been shown to play a critical role for the induction of homing receptors on conventional T cells. 
Whereas in vitro T cell activation by intestinal DCs from PP and mLN is necessary and sufficient to 
generate a α4β7+ gut-homing phenotype, DCs isolated from pLNs induce higher levels of selectin 
ligands than intestinal DCs (Dudda, et al., 2004; Johansson-Lindbom, et al., 2003; Mora, et al., 2003; 
Stagg, et al., 2002). 
The findings obtained in the current study using ex vivo isolated organ-specific CD11c+ DCs to 
stimulate naïve Tregs in vitro, were largely in line with previous reports on cultures of conventional T 
cells in the presence of DCs isolated from either skin-draining or gut-draining lymphoid organs. 
Recent studies by Annacker et al. and Johansson-Lindbom et al. (Annacker, et al., 2005; Johansson-
Lindbom, et al., 2005) identified a subset of mLN-DCs characterised by the expression of αE, which 
selectively induced CCR9 and α4β7 expression on T cells upon antigen-specific activation in vitro. In 
co-cultures with CD8+ OT-I cells CCR9 and α4β7 were only incuced by αE+CD11c+ DCs but not in the 
presence of αE-CD11c+ DCs. In contrast, cultured CD4+ OT-II cells up-regulated expression of α4β7 in 
presence of either DC subset, while CCR9 expression was only induced by αE+CD11c+ DCs 
(Johansson-Lindbom, et al., 2005). The above findings indicate that expression of α4β7 and CCR9 is 
differentially regulated in CD4+ T cells, while in CD8+ T cells the induction of both homing receptors 
appeared to require similar molecular signals. The results obtained in our study showing selective 
induction of α4β7, but not CCR9 on CD25+ Tregs co-cultured with mLN-derived DCs may therefore 
reflect insufficient numbers of αE+CD11c+ among the whole mLN-derived CD11c+ fraction and 
support the concept that expression of these two gut-specific homing receptors is differentially 
regulated not only in conventional CD4+ T cells but also in CD4+CD25+ Tregs.  
Similar to results obtained previously with CD8+ T cells (Mora, et al., 2005), in the study presented 
here “default” induction of P-Lig in co-cultures with mLN-derived DCs was observed. Cultures in the 
presence of pLN-derived DCs led to only slightly increased frequencies of P-Lig+ cells. This was in 
line with previous findings by our group, where P-Lig-expression was induced on conventional naïve 
T cells in the presence of mLN and PP-derived DCs, albeit to a lower degree than in the presence of 
pLN-derived DCs (unpublished observation).  
Taken together, the results obtained during activation of naïve CD25+ Tregs in co-cultures with tissue-
specific ex vivo isolated DCs indicate that Tregs largely respond to the same stimuli as conventional 
T cells and acquire gut-specific and skin-specific homing receptor expression, respectively. 
 
CD25+ Tregs respond to soluble factors  
Among the molecular factors that control the induction of homing receptor expression on T cells, RA 
has recently been shown to play a critical role for the generation of gut-tropic T cells (Iwata, et al., 
2004). In a thorough study these authors identified the causative link between lack of effector/memory 
T cells in the gut mucosa of vitamin A deficient mice and the molecular mechanisms involved in the 
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induction of gut-tropic T cells. They found that only intestinal DCs from PP and mLN, but not splenic 
or pLN-derived DCs, expressed retinal dehydrogenase isoenzymes required for conversion of RA 
from the vitamin A metabolite retinal. In turn, RA that binds to nuclear receptors for RA (RAR and 
RXR), which function as heterodimeric ligand-inducible transcription factors, induced expression of 
α4β7 and CCR9 in T cells (Iwata, et al., 2004). Consistent with a pivotal role of RA during intestinal 
imprinting, effector T cells that are stimulated in the presence of exogenous RA acquire a marked gut-
homing phenotype irrespective of their prior tissue commitment or the nature of the activating 
stimulus (Mora and von Andrian, 2006). These findings suggest that RA dominantly controls the 
establishment of gut-specific homing.  
Our data demonstrate that also Tregs are susceptible to RA and can be converted into an α4β7-
expressing gut-homing phenotype by activation in the presence of RA. Yet, induction of CCR9 was 
only observed on a minor fraction of Tregs in the presence of RA. Induction was dose-dependent and 
lower doses of RA (1 nM) did not consistently induce CCR9 expression under the experimental 
conditions used here (data not shown).  
Similar to what was found for the co-cultures with organ-specific DCs, induction of P-Lig expression 
on Tregs under the influence of polarising factors was less selectively controlled, with IL-12 having 
only an additive effect. This was in contrast to E-Lig expression, which was suppressed upon addition 
of RA, as has been reported previously (Iwata, et al., 2004). Our findings suggest that distinct 
pathways control expression of the two functional selectin ligands in Tregs.  
Blocking of residual IL-12 activity by addition of an anti-IL-12 mAb in RA and neutral cultures did 
not prevent P-Lig induction on Tregs, indicating that a molecular mechanism independent of IL-12 
and insensitive to RA-derived signals may be involved. In line with our observation, White and 
colleagues demonstrated that T cell activation alone induced expression of FucT-VII, which is 
required for expression of functional E/P-Lig (White, et al., 2001).  
Based on these findings a role for pathways independent of IL-12, but associated with TCR-
stimulation may be relevant for induction of P-Lig in Tregs, at least under the culture conditions used 
here. Clearly, the basis of the distinct molecular mechanisms should be subject of future studies.  
 
CD25+ Tregs maintain their phenotypic characteristics upon in vitro modulation  
Having established that naïve CD25+ Tregs can acquire distinct homing receptor phenotypes upon 
culture with the appropriate signals, an important issue was to analyse the effect of such treatment on 
the expression of the Treg specific transcription factor Foxp3. Importantly, the vast majority of CD25+ 
Tregs continued to express Foxp3 following the culture period. RA-cultured Tregs expressed the 
highest frequency of Foxp3+ cells followed by Tregs cultured under neutral conditions. Addition of 
IL-12 led to slightly, but significantly reduced frequencies of Foxp3+ cells. Another observation made 
during the culture experiments was the fact that only sorting for CD25+CD62Lhigh Tregs, but not for 
naïve-like αE-CD25+ Tregs, yielded high frequencies of Foxp3-expressing cells, suggesting that some 
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contaminating αE-CD25+ non-regulatory effector cells might over-grow the cultures (data not shown). 
A similar observation has been reported for human CD25+ Tregs showing that only the naïve 
CD25+CD45RA+ fraction gave rise to stable Foxp3-expressing Tregs (Hoffmann, et al., 2006). In 
contrast, during in vivo activation of naïve-like αE-CD25+ consistently high frequencies of Foxp3+ 
cells were maintained upon both oral and i.p. immunisation (Figure 12 and data not shown). These 
differential findings may reflect the requirement of additional factors for maintenance of Foxp3-
expression i.e. TGF-β as discussed above or other cell contact dependent signals.   
Nevertheless, despite the somewhat reduced frequency of Foxp3+ cells, Tregs cultured in the presence 
of IL-12 were as effective as neutral or RA-cultured Tregs in suppressing proliferation of naïve CFSE-
labelled responder cells in an in vitro assay. The suppressive capacity of all expanded Tregs was 
comparable to to freshly isolated CD25+ Tregs. These results suggest that expansion of Tregs under 
conditions, which modulate the homing receptor phenotype, do not change their principle 
characteristics such as Foxp3-expression and in vitro suppression of T cell proliferation. 
 
Migratory properties of in vitro modulated CD25+ Tregs 
Analysis of the migration behaviour of the in vitro polarised Tregs showed that upon adoptive transfer 
Tregs cultured under polarising conditions displayed selective organ-specific homing properties. 
Inflamed skin selectively recruited IL-12-cultured Tregs, while migration to gut and GALT was most 
prominent, though not exclusive, for Tregs cultured in the presence of RA. Low-level expression of 
α4β7 on neutral and IL-12-cultured Tregs may have been sufficient to enable homing to the intestine 
and associated lymphoid tissue. In addition, although it has been repeatedly demonstrated that the 
integrin α4β7 is important for migration of T cells into both the non-inflamed as well as the inflamed 
intestine (Berlin, et al., 1993; Hamann, et al., 1994; Holzmann and Weissman, 1989), an additional 
role of LFA-1 and selectins and their ligands has also been shown by others (Haddad, et al., 2003; 
Lefrancois, et al., 1999; Rivera-Nieves, et al., 2005) and in our own lab (unpublished data). In 
contrast, P-Lig expression detected on RA-cultured Tregs was not sufficient to allow trafficking to 
inflamed skin indicating that either E-Lig expression was crucial or alterations in expression or 
functional activity of other homing-related receptors contributed to the increased inflammation-
seeking capacity of IL-12-treated Tregs. 
These findings confirmed the functionality of the induced homing receptor phenotype and further 
supported the notion that Tregs are equally susceptible to the molecular factors controlling expression 
of adhesion molecules and chemokine receptors as conventional CD4+ T cells. However, previous 
work with conventional T cells revealed an unexpected degree of convertibility in the migration 
behaviour. The results suggested that peripheral tissue commitment of conventional memory T cells 
was not a stable property, but apparently reflected dynamic functional states (Dudda, et al., 2005; 
Mora, et al., 2005). Nevertheless, results from our group observed significant stability of a P-Lig+ 
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phenotype over prolonged periods in vivo, at least in a subfraction of conventional effector/memory T 
cells (Jennrich et al., manuscript submitted (Jennrich, et al., in revision)). 
Thus, it remains to be shown to what extent induced homing phenotypes can become stably imprinted 
and whether this also applies to Tregs.  
 
Use of in vitro cultured Tregs for adoptive transfer 
The data presented here indicate that Tregs display similar plasticity with respect to the instruction to 
specific homing by activation within distinct microenvironments. This suggests that a custom 
modulation of Tregs designed to serve therapeutic purposes in adoptive T cell therapy might be 
feasible and provides the option to generate Treg populations with specific homing properties. To 
date, only few studies have shown that adoptive transfer is a feasible therapeutic option in established 
disease. Suri-Payer and colleagues demonstrated that CD4+CD25+ suppressed not only the induction 
of autoimmune disease in thymectomised recipients, but also efficiently suppressed disease induced by 
cloned autoantigen-specific effector cells (Suri-Payer, et al., 1998). In models of experimental colitis 
cure of intestinal inflammation was achieved upon transfer of ex vivo isolated or activated CD25+CD4+ 
Tregs (Liu, et al., 2003; Mottet, et al., 2003). Tang and colleagues demonstrated that small numbers of 
antigen-specific in vitro expanded Tregs were able to reverse established diabetes (Tang, et al., 2004). 
It will of course be interesting to investigate the efficiency of Tregs instructed to acquire specific 
homing properties in ongoing immune reactions such as autoimmunity or chronic inflammation. 
However, preliminary experiments from our group in the DTH model of acute skin-inflammation 
revealed only moderate efficiency of in vitro expanded Tregs per se. Despite selective short-term 
recruitment of IL-12-cultured Tregs they were only marginally superior to RA-cultured Tregs in 
ameliorating the inflammatory response (Appendix 3). Furthermore, although they remained Foxp3+ 
and preserved in vitro suppressive capacity, cultured Tregs were less effective in this model compared 
to ex vivo isolated effector/memory-like αE+ Tregs as shown previously (Siegmund, et al., 2005). The 
exact mechanisms responsible for effective suppressor function of Tregs in vivo are currently 
unknown and a role for a number of soluble and/or surface molecules has been proposed (reviewed in 
(von Boehmer, 2005)). In particular, it is not clear how well in vitro suppressive mechanisms reflect 
relevant in vivo mechanisms. Nevertheless, suppressive capacity in vitro seems to be a minimum 
requirement for potential therapeutic use of expanded Tregs.  
These preliminary findings highlight the necessity for an optimised culture system aimed to preserve 
the intrinsic functional properties of isolated Tregs and for establishment of informative in vitro assays 
allowing a more precise prediction of in vivo function of cultured Tregs. Furthermore, the therapeutic 
effect of adoptively transferred Tregs may be different in individual disease models and thus, careful 
evaluation will be necessary to examine the feasibility of curative Treg transfer strategies. 
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4.4 Conclusion and Outlook 
The results obtained in this study support the notion that multiple factors in secondary lymphoid tissue 
contribute to the continuation of immune homeostasis by providing various stimuli for expansion and 
maintenance of Tregs in the periphery. The physiological relevance of intestinal colonisation by 
commensal microbes is illustrated by the finding that Foxp3+ Treg numbers were substantially 
decreased in gnotobiotic mice. The proportion and absolute number of proliferating Tregs were 
reduced in these mice, suggesting that local responses in GALT impact on the homeostasis of the 
peripheral Treg pool. It will be interesting to investigate in future studies the basis of the observed 
effect of intestinal microflora, particularly whether the pool of thymic-derived self-reactive Tregs 
harbours sufficient diversity in order to directly recognise bacterial antigen. This can be addressed 
using in vitro culture systems of GALT-derived CD25+ Tregs together with DCs and bacterial protein 
pools. Antigen-specific recognition should result in proliferation of Tregs and up-regulation of 
activation markers. Alternatively, other stimuli such as TLR-mediated signalling may contribute to 
peripheral expansion and maintenance of Tregs. This issue can be addressed by using Tregs from e.g. 
TLR-2-/-, TLR-4-/- or MyD88-/- mice that are impaired in their capacity to respond to microbial products 
such as peptidoglycan and LPS.  
In addition, the results achieved here demonstrate that oral antigen leads to antigen-specific expansion 
of pre-formed thymic-derived Tregs as well as to de novo induction of Foxp3+ Tregs. This, in 
combination with the observed role of the commensal microflora, provides an important mechanism 
for the maintenance of Tregs and indicates that the mucosal microenvironment favours both expansion 
and conversion of Tregs. A currently unsolved issue relates to the stability of de novo induced Foxp3+ 
T cells. Re-isolation and adoptive transfer into secondary hosts can be used to address this question 
and to determine, whether a stable cell lineage has been generated during oral tolerance induction. In 
this respect the use of T cells from GFP-Foxp3 reporter mice will be extremely helpful, as it allows re-
isolation and FACS sorting of oral antigen-induced GFP-Foxp3-expressing cells for further functional 
analysis and for survival studies. In addition, this would permit analysis of the methylation status of 
the foxp3 gene in de novo induced Foxp3+ T cells in comparison to thymic-derived Foxp3+ Tregs.  
With regard to the homing receptor phenotype of Tregs, the results obtained here indicate that Tregs 
display similar plasticity as conventional T cells with respect to the instruction to specific homing by 
activation within distinct microenvironments. This can be regarded as proof of principle and suggests 
that the option to generate Treg populations with specific homing properties for therapeutic purposes 
in adoptive T cell therapy might be feasible. However, various important issues remain unsolved to 
date, including the stability of the induced homing phenotype and in vivo functional properties of 
expanded Tregs. Adoptive transfer experiments with and without re-stimulation in vivo can help to 
determine the stability of organ-specific phenotypes on Tregs. An important issue is to determine the 
usefulness of in vitro assays with respect to the corresponding in vivo suppressive capacity of Tregs. 
Ultimately, to test their functional properties, use of expanded Tregs in prevention and cure of disease 
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in animal models such as experimental colitis have to be performed. They should provide further 
insights into the feasibility of therapeutic concepts based on adoptive transfer of expanded Tregs with 
selective tissue-tropism.  
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6 Appendix 
6.1 Appendix 1 
 
 
Appendix 1: Microbial stimuli influence cell umbers of Foxp3+ αE/CD25 Treg subsets 
C57BL/6 mice were treated with a cocktail of antibiotics ad libitum for a period of 8-10 weeks. Upon successful 
eradication of the intestinal microflora mice were analysed for the frequency and cell number of CD4+ T cell 
subsets and compared to untreated control mice. Enumeration of lymphocyte numbers was done as described in 
Figure 9 and Foxp3-gated cells were analysed for the frequency and cell number of αE/CD25 Tregs. (a) 
Representative dot plots showing staining of CD4 vs. Foxp3 on lymphocytes isolated from mLN of control mice 
(left) and staining of αE vs. CD25 on CD4+Foxp3+ gated cells (right). (b) Frequency of αE/CD25 Treg subsets 
among CD4+Foxp3+ cells in indicated organs from untreated control mice (open symbols) and antibiotics-treated 
mice (closed symbols). (c) Cell numbers of CD4+Foxp3+ αE/CD25 Tregs in indicated organs. Graphs include data 
from two independent experiments, symbols represent individual mice and lines indicate the median. * p < 0.05; 
** p < 0.01. 
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6.2 Appendix 2 
 
 
Appendix 2: Dose-dependent proliferation of transferred naïve CD25- DO11.10 cells after oral antigen application 
Naïve T cells were isolated from DO11.10 mice by depleting αE+ and CD25+ cells and subsequent isolation of 
CD62Lhigh cells. Purified αE-CD25-CD62Lhigh T cells were labelled with CFSE, adoptively transferred into BALB/c 
recipients and subsequently stimulated in vivo by oral application of their cognate antigen. After 6 days of 
continuous feeding with OVA, mice were sacrificed and lymphocytes were analysed by flow cytometry. 
Transferred cells were identified according to CD4+KJ1.26+ staining and CFSE. (a) Dotplots show representative 
staining of KJ1.26 and CFSE on CD4+ gated cells from indicated lymphoid organs. Proliferation of re-isolated 
DO11.10 T cells after feeding of different doses of OVA was assessed by loss of CFSE of KJ1.24+ cells and is 
expressed as GMFI of CFSE in gated regions. (b) GMFI of CFSE of re-isolated CD4+KJ1.26+ T cells in indicated 
lymphoid organs after different doses of OVA in drinking water. Mean ± SD from 3-4 individual mice per group. 
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6.3 Appendix 3 
 
 
 
Appendix 3: In vivo suppressive potential of in vitro polarised Tregs. 
Naïve CD4+CD25+CD62Lhigh Tregs were isolated from DO11.10 mice and stimulated with OVA323-339 peptide and 
CD90- APC under polarising conditions for 6 days. Cultured Tregs were harvested and adoptively transferred 
together with OVA-specific Th1 cells at a ratio of 1 : 2 (Treg : Th1). Control animals received only Th1 cells 
(PBS). One day later the DTH response was triggered by injecting OVA323-339 peptide/IFA into one footpad as 
described in 2.2.5.4. The swelling of the footpad was followed over time and measured daily as described 
previously (Siegmund, et al., 2005). Graphs display mean footpad thickness ± SD from 4 to 7 individual mice per 
group.  
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